US20040039255A1 - Medical system and a method of controlling the system for use by a patient for medical self treatment - Google Patents
Medical system and a method of controlling the system for use by a patient for medical self treatment Download PDFInfo
- Publication number
- US20040039255A1 US20040039255A1 US10/342,150 US34215003A US2004039255A1 US 20040039255 A1 US20040039255 A1 US 20040039255A1 US 34215003 A US34215003 A US 34215003A US 2004039255 A1 US2004039255 A1 US 2004039255A1
- Authority
- US
- United States
- Prior art keywords
- information
- medical system
- apparatuses
- patient
- data
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Abandoned
Links
Images
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61B—DIAGNOSIS; SURGERY; IDENTIFICATION
- A61B5/00—Measuring for diagnostic purposes; Identification of persons
- A61B5/145—Measuring characteristics of blood in vivo, e.g. gas concentration, pH value; Measuring characteristics of body fluids or tissues, e.g. interstitial fluid, cerebral tissue
- A61B5/14532—Measuring characteristics of blood in vivo, e.g. gas concentration, pH value; Measuring characteristics of body fluids or tissues, e.g. interstitial fluid, cerebral tissue for measuring glucose, e.g. by tissue impedance measurement
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61B—DIAGNOSIS; SURGERY; IDENTIFICATION
- A61B5/00—Measuring for diagnostic purposes; Identification of persons
- A61B5/0002—Remote monitoring of patients using telemetry, e.g. transmission of vital signals via a communication network
- A61B5/0015—Remote monitoring of patients using telemetry, e.g. transmission of vital signals via a communication network characterised by features of the telemetry system
- A61B5/0022—Monitoring a patient using a global network, e.g. telephone networks, internet
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61B—DIAGNOSIS; SURGERY; IDENTIFICATION
- A61B5/00—Measuring for diagnostic purposes; Identification of persons
- A61B5/15—Devices for taking samples of blood
- A61B5/150007—Details
- A61B5/150015—Source of blood
- A61B5/150022—Source of blood for capillary blood or interstitial fluid
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61B—DIAGNOSIS; SURGERY; IDENTIFICATION
- A61B5/00—Measuring for diagnostic purposes; Identification of persons
- A61B5/15—Devices for taking samples of blood
- A61B5/150007—Details
- A61B5/150206—Construction or design features not otherwise provided for; manufacturing or production; packages; sterilisation of piercing element, piercing device or sampling device
- A61B5/150267—Modular design or construction, i.e. subunits are assembled separately before being joined together or the device comprises interchangeable or detachable modules
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61B—DIAGNOSIS; SURGERY; IDENTIFICATION
- A61B5/00—Measuring for diagnostic purposes; Identification of persons
- A61B5/15—Devices for taking samples of blood
- A61B5/150007—Details
- A61B5/150206—Construction or design features not otherwise provided for; manufacturing or production; packages; sterilisation of piercing element, piercing device or sampling device
- A61B5/150305—Packages specially adapted for piercing devices or blood sampling devices
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61B—DIAGNOSIS; SURGERY; IDENTIFICATION
- A61B5/00—Measuring for diagnostic purposes; Identification of persons
- A61B5/15—Devices for taking samples of blood
- A61B5/151—Devices specially adapted for taking samples of capillary blood, e.g. by lancets, needles or blades
- A61B5/15101—Details
- A61B5/15103—Piercing procedure
- A61B5/15107—Piercing being assisted by a triggering mechanism
- A61B5/15113—Manually triggered, i.e. the triggering requires a deliberate action by the user such as pressing a drive button
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61B—DIAGNOSIS; SURGERY; IDENTIFICATION
- A61B5/00—Measuring for diagnostic purposes; Identification of persons
- A61B5/15—Devices for taking samples of blood
- A61B5/157—Devices characterised by integrated means for measuring characteristics of blood
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61J—CONTAINERS SPECIALLY ADAPTED FOR MEDICAL OR PHARMACEUTICAL PURPOSES; DEVICES OR METHODS SPECIALLY ADAPTED FOR BRINGING PHARMACEUTICAL PRODUCTS INTO PARTICULAR PHYSICAL OR ADMINISTERING FORMS; DEVICES FOR ADMINISTERING FOOD OR MEDICINES ORALLY; BABY COMFORTERS; DEVICES FOR RECEIVING SPITTLE
- A61J1/00—Containers specially adapted for medical or pharmaceutical purposes
- A61J1/03—Containers specially adapted for medical or pharmaceutical purposes for pills or tablets
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61J—CONTAINERS SPECIALLY ADAPTED FOR MEDICAL OR PHARMACEUTICAL PURPOSES; DEVICES OR METHODS SPECIALLY ADAPTED FOR BRINGING PHARMACEUTICAL PRODUCTS INTO PARTICULAR PHYSICAL OR ADMINISTERING FORMS; DEVICES FOR ADMINISTERING FOOD OR MEDICINES ORALLY; BABY COMFORTERS; DEVICES FOR RECEIVING SPITTLE
- A61J7/00—Devices for administering medicines orally, e.g. spoons; Pill counting devices; Arrangements for time indication or reminder for taking medicine
- A61J7/04—Arrangements for time indication or reminder for taking medicine, e.g. programmed dispensers
- A61J7/0409—Arrangements for time indication or reminder for taking medicine, e.g. programmed dispensers with timers
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61M—DEVICES FOR INTRODUCING MEDIA INTO, OR ONTO, THE BODY; DEVICES FOR TRANSDUCING BODY MEDIA OR FOR TAKING MEDIA FROM THE BODY; DEVICES FOR PRODUCING OR ENDING SLEEP OR STUPOR
- A61M15/00—Inhalators
- A61M15/0065—Inhalators with dosage or measuring devices
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61M—DEVICES FOR INTRODUCING MEDIA INTO, OR ONTO, THE BODY; DEVICES FOR TRANSDUCING BODY MEDIA OR FOR TAKING MEDIA FROM THE BODY; DEVICES FOR PRODUCING OR ENDING SLEEP OR STUPOR
- A61M5/00—Devices for bringing media into the body in a subcutaneous, intra-vascular or intramuscular way; Accessories therefor, e.g. filling or cleaning devices, arm-rests
- A61M5/178—Syringes
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61M—DEVICES FOR INTRODUCING MEDIA INTO, OR ONTO, THE BODY; DEVICES FOR TRANSDUCING BODY MEDIA OR FOR TAKING MEDIA FROM THE BODY; DEVICES FOR PRODUCING OR ENDING SLEEP OR STUPOR
- A61M5/00—Devices for bringing media into the body in a subcutaneous, intra-vascular or intramuscular way; Accessories therefor, e.g. filling or cleaning devices, arm-rests
- A61M5/178—Syringes
- A61M5/31—Details
- A61M5/315—Pistons; Piston-rods; Guiding, blocking or restricting the movement of the rod or piston; Appliances on the rod for facilitating dosing ; Dosing mechanisms
- A61M5/31533—Dosing mechanisms, i.e. setting a dose
- A61M5/31545—Setting modes for dosing
-
- G—PHYSICS
- G16—INFORMATION AND COMMUNICATION TECHNOLOGY [ICT] SPECIALLY ADAPTED FOR SPECIFIC APPLICATION FIELDS
- G16H—HEALTHCARE INFORMATICS, i.e. INFORMATION AND COMMUNICATION TECHNOLOGY [ICT] SPECIALLY ADAPTED FOR THE HANDLING OR PROCESSING OF MEDICAL OR HEALTHCARE DATA
- G16H20/00—ICT specially adapted for therapies or health-improving plans, e.g. for handling prescriptions, for steering therapy or for monitoring patient compliance
- G16H20/10—ICT specially adapted for therapies or health-improving plans, e.g. for handling prescriptions, for steering therapy or for monitoring patient compliance relating to drugs or medications, e.g. for ensuring correct administration to patients
- G16H20/17—ICT specially adapted for therapies or health-improving plans, e.g. for handling prescriptions, for steering therapy or for monitoring patient compliance relating to drugs or medications, e.g. for ensuring correct administration to patients delivered via infusion or injection
-
- G—PHYSICS
- G16—INFORMATION AND COMMUNICATION TECHNOLOGY [ICT] SPECIALLY ADAPTED FOR SPECIFIC APPLICATION FIELDS
- G16H—HEALTHCARE INFORMATICS, i.e. INFORMATION AND COMMUNICATION TECHNOLOGY [ICT] SPECIALLY ADAPTED FOR THE HANDLING OR PROCESSING OF MEDICAL OR HEALTHCARE DATA
- G16H40/00—ICT specially adapted for the management or administration of healthcare resources or facilities; ICT specially adapted for the management or operation of medical equipment or devices
- G16H40/60—ICT specially adapted for the management or administration of healthcare resources or facilities; ICT specially adapted for the management or operation of medical equipment or devices for the operation of medical equipment or devices
- G16H40/67—ICT specially adapted for the management or administration of healthcare resources or facilities; ICT specially adapted for the management or operation of medical equipment or devices for the operation of medical equipment or devices for remote operation
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61B—DIAGNOSIS; SURGERY; IDENTIFICATION
- A61B2560/00—Constructional details of operational features of apparatus; Accessories for medical measuring apparatus
- A61B2560/04—Constructional details of apparatus
- A61B2560/0406—Constructional details of apparatus specially shaped apparatus housings
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61B—DIAGNOSIS; SURGERY; IDENTIFICATION
- A61B2560/00—Constructional details of operational features of apparatus; Accessories for medical measuring apparatus
- A61B2560/04—Constructional details of apparatus
- A61B2560/0443—Modular apparatus
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61B—DIAGNOSIS; SURGERY; IDENTIFICATION
- A61B2562/00—Details of sensors; Constructional details of sensor housings or probes; Accessories for sensors
- A61B2562/02—Details of sensors specially adapted for in-vivo measurements
- A61B2562/0219—Inertial sensors, e.g. accelerometers, gyroscopes, tilt switches
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61B—DIAGNOSIS; SURGERY; IDENTIFICATION
- A61B5/00—Measuring for diagnostic purposes; Identification of persons
- A61B5/15—Devices for taking samples of blood
- A61B5/150007—Details
- A61B5/150358—Strips for collecting blood, e.g. absorbent
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61B—DIAGNOSIS; SURGERY; IDENTIFICATION
- A61B5/00—Measuring for diagnostic purposes; Identification of persons
- A61B5/15—Devices for taking samples of blood
- A61B5/150007—Details
- A61B5/150374—Details of piercing elements or protective means for preventing accidental injuries by such piercing elements
- A61B5/150381—Design of piercing elements
- A61B5/150412—Pointed piercing elements, e.g. needles, lancets for piercing the skin
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61B—DIAGNOSIS; SURGERY; IDENTIFICATION
- A61B5/00—Measuring for diagnostic purposes; Identification of persons
- A61B5/72—Signal processing specially adapted for physiological signals or for diagnostic purposes
- A61B5/7235—Details of waveform analysis
- A61B5/7264—Classification of physiological signals or data, e.g. using neural networks, statistical classifiers, expert systems or fuzzy systems
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61J—CONTAINERS SPECIALLY ADAPTED FOR MEDICAL OR PHARMACEUTICAL PURPOSES; DEVICES OR METHODS SPECIALLY ADAPTED FOR BRINGING PHARMACEUTICAL PRODUCTS INTO PARTICULAR PHYSICAL OR ADMINISTERING FORMS; DEVICES FOR ADMINISTERING FOOD OR MEDICINES ORALLY; BABY COMFORTERS; DEVICES FOR RECEIVING SPITTLE
- A61J7/00—Devices for administering medicines orally, e.g. spoons; Pill counting devices; Arrangements for time indication or reminder for taking medicine
- A61J7/04—Arrangements for time indication or reminder for taking medicine, e.g. programmed dispensers
- A61J7/0409—Arrangements for time indication or reminder for taking medicine, e.g. programmed dispensers with timers
- A61J7/0454—Arrangements for time indication or reminder for taking medicine, e.g. programmed dispensers with timers for dispensing of multiple drugs
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61M—DEVICES FOR INTRODUCING MEDIA INTO, OR ONTO, THE BODY; DEVICES FOR TRANSDUCING BODY MEDIA OR FOR TAKING MEDIA FROM THE BODY; DEVICES FOR PRODUCING OR ENDING SLEEP OR STUPOR
- A61M15/00—Inhalators
- A61M15/0065—Inhalators with dosage or measuring devices
- A61M15/0066—Inhalators with dosage or measuring devices with means for varying the dose size
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61M—DEVICES FOR INTRODUCING MEDIA INTO, OR ONTO, THE BODY; DEVICES FOR TRANSDUCING BODY MEDIA OR FOR TAKING MEDIA FROM THE BODY; DEVICES FOR PRODUCING OR ENDING SLEEP OR STUPOR
- A61M15/00—Inhalators
- A61M15/0065—Inhalators with dosage or measuring devices
- A61M15/0068—Indicating or counting the number of dispensed doses or of remaining doses
- A61M15/008—Electronic counters
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61M—DEVICES FOR INTRODUCING MEDIA INTO, OR ONTO, THE BODY; DEVICES FOR TRANSDUCING BODY MEDIA OR FOR TAKING MEDIA FROM THE BODY; DEVICES FOR PRODUCING OR ENDING SLEEP OR STUPOR
- A61M5/00—Devices for bringing media into the body in a subcutaneous, intra-vascular or intramuscular way; Accessories therefor, e.g. filling or cleaning devices, arm-rests
- A61M5/178—Syringes
- A61M5/31—Details
- A61M2005/3125—Details specific display means, e.g. to indicate dose setting
- A61M2005/3126—Specific display means related to dosing
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61M—DEVICES FOR INTRODUCING MEDIA INTO, OR ONTO, THE BODY; DEVICES FOR TRANSDUCING BODY MEDIA OR FOR TAKING MEDIA FROM THE BODY; DEVICES FOR PRODUCING OR ENDING SLEEP OR STUPOR
- A61M2205/00—General characteristics of the apparatus
- A61M2205/05—General characteristics of the apparatus combined with other kinds of therapy
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61M—DEVICES FOR INTRODUCING MEDIA INTO, OR ONTO, THE BODY; DEVICES FOR TRANSDUCING BODY MEDIA OR FOR TAKING MEDIA FROM THE BODY; DEVICES FOR PRODUCING OR ENDING SLEEP OR STUPOR
- A61M2205/00—General characteristics of the apparatus
- A61M2205/18—General characteristics of the apparatus with alarm
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61M—DEVICES FOR INTRODUCING MEDIA INTO, OR ONTO, THE BODY; DEVICES FOR TRANSDUCING BODY MEDIA OR FOR TAKING MEDIA FROM THE BODY; DEVICES FOR PRODUCING OR ENDING SLEEP OR STUPOR
- A61M2205/00—General characteristics of the apparatus
- A61M2205/35—Communication
- A61M2205/3546—Range
- A61M2205/3553—Range remote, e.g. between patient's home and doctor's office
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61M—DEVICES FOR INTRODUCING MEDIA INTO, OR ONTO, THE BODY; DEVICES FOR TRANSDUCING BODY MEDIA OR FOR TAKING MEDIA FROM THE BODY; DEVICES FOR PRODUCING OR ENDING SLEEP OR STUPOR
- A61M2205/00—General characteristics of the apparatus
- A61M2205/35—Communication
- A61M2205/3546—Range
- A61M2205/3561—Range local, e.g. within room or hospital
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61M—DEVICES FOR INTRODUCING MEDIA INTO, OR ONTO, THE BODY; DEVICES FOR TRANSDUCING BODY MEDIA OR FOR TAKING MEDIA FROM THE BODY; DEVICES FOR PRODUCING OR ENDING SLEEP OR STUPOR
- A61M2205/00—General characteristics of the apparatus
- A61M2205/35—Communication
- A61M2205/3546—Range
- A61M2205/3569—Range sublocal, e.g. between console and disposable
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61M—DEVICES FOR INTRODUCING MEDIA INTO, OR ONTO, THE BODY; DEVICES FOR TRANSDUCING BODY MEDIA OR FOR TAKING MEDIA FROM THE BODY; DEVICES FOR PRODUCING OR ENDING SLEEP OR STUPOR
- A61M2205/00—General characteristics of the apparatus
- A61M2205/35—Communication
- A61M2205/3576—Communication with non implanted data transmission devices, e.g. using external transmitter or receiver
- A61M2205/3584—Communication with non implanted data transmission devices, e.g. using external transmitter or receiver using modem, internet or bluetooth
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61M—DEVICES FOR INTRODUCING MEDIA INTO, OR ONTO, THE BODY; DEVICES FOR TRANSDUCING BODY MEDIA OR FOR TAKING MEDIA FROM THE BODY; DEVICES FOR PRODUCING OR ENDING SLEEP OR STUPOR
- A61M2205/00—General characteristics of the apparatus
- A61M2205/35—Communication
- A61M2205/3576—Communication with non implanted data transmission devices, e.g. using external transmitter or receiver
- A61M2205/3592—Communication with non implanted data transmission devices, e.g. using external transmitter or receiver using telemetric means, e.g. radio or optical transmission
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61M—DEVICES FOR INTRODUCING MEDIA INTO, OR ONTO, THE BODY; DEVICES FOR TRANSDUCING BODY MEDIA OR FOR TAKING MEDIA FROM THE BODY; DEVICES FOR PRODUCING OR ENDING SLEEP OR STUPOR
- A61M2205/00—General characteristics of the apparatus
- A61M2205/50—General characteristics of the apparatus with microprocessors or computers
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61M—DEVICES FOR INTRODUCING MEDIA INTO, OR ONTO, THE BODY; DEVICES FOR TRANSDUCING BODY MEDIA OR FOR TAKING MEDIA FROM THE BODY; DEVICES FOR PRODUCING OR ENDING SLEEP OR STUPOR
- A61M2205/00—General characteristics of the apparatus
- A61M2205/50—General characteristics of the apparatus with microprocessors or computers
- A61M2205/502—User interfaces, e.g. screens or keyboards
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61M—DEVICES FOR INTRODUCING MEDIA INTO, OR ONTO, THE BODY; DEVICES FOR TRANSDUCING BODY MEDIA OR FOR TAKING MEDIA FROM THE BODY; DEVICES FOR PRODUCING OR ENDING SLEEP OR STUPOR
- A61M2205/00—General characteristics of the apparatus
- A61M2205/50—General characteristics of the apparatus with microprocessors or computers
- A61M2205/52—General characteristics of the apparatus with microprocessors or computers with memories providing a history of measured variating parameters of apparatus or patient
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61M—DEVICES FOR INTRODUCING MEDIA INTO, OR ONTO, THE BODY; DEVICES FOR TRANSDUCING BODY MEDIA OR FOR TAKING MEDIA FROM THE BODY; DEVICES FOR PRODUCING OR ENDING SLEEP OR STUPOR
- A61M2230/00—Measuring parameters of the user
- A61M2230/20—Blood composition characteristics
- A61M2230/201—Glucose concentration
-
- G—PHYSICS
- G16—INFORMATION AND COMMUNICATION TECHNOLOGY [ICT] SPECIALLY ADAPTED FOR SPECIFIC APPLICATION FIELDS
- G16H—HEALTHCARE INFORMATICS, i.e. INFORMATION AND COMMUNICATION TECHNOLOGY [ICT] SPECIALLY ADAPTED FOR THE HANDLING OR PROCESSING OF MEDICAL OR HEALTHCARE DATA
- G16H10/00—ICT specially adapted for the handling or processing of patient-related medical or healthcare data
- G16H10/60—ICT specially adapted for the handling or processing of patient-related medical or healthcare data for patient-specific data, e.g. for electronic patient records
-
- G—PHYSICS
- G16—INFORMATION AND COMMUNICATION TECHNOLOGY [ICT] SPECIALLY ADAPTED FOR SPECIFIC APPLICATION FIELDS
- G16H—HEALTHCARE INFORMATICS, i.e. INFORMATION AND COMMUNICATION TECHNOLOGY [ICT] SPECIALLY ADAPTED FOR THE HANDLING OR PROCESSING OF MEDICAL OR HEALTHCARE DATA
- G16H50/00—ICT specially adapted for medical diagnosis, medical simulation or medical data mining; ICT specially adapted for detecting, monitoring or modelling epidemics or pandemics
- G16H50/20—ICT specially adapted for medical diagnosis, medical simulation or medical data mining; ICT specially adapted for detecting, monitoring or modelling epidemics or pandemics for computer-aided diagnosis, e.g. based on medical expert systems
-
- Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
- Y10—TECHNICAL SUBJECTS COVERED BY FORMER USPC
- Y10S—TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
- Y10S128/00—Surgery
- Y10S128/903—Radio telemetry
Definitions
- This invention comprises a medical system and a method of controlling the system for use by a patient for medical self treatment.
- the individual devices may be arranged for various respective functions relevant to the treatment of e.g. diabetes, such as: a lancet device, a body fluid analyser, one or more drug administration apparatuses for administering a predetermined dose of medication to the patient.
- a lancet device e.g., a lancet device
- a body fluid analyser e.g., a body fluid analyser
- drug administration apparatuses for administering a predetermined dose of medication to the patient.
- other aids which the diabetic patient uses, e.g. test strips for the blood analyser, needles, napkins for wiping off blood, extra insulin carpoule, glucose tablets, waste containers, etc.
- the object of the invention is to provide a method for effective monitoring of electronic data relevant to a plurality of apparatuses which are used by a patient for self-treatment of a disease, so that a greater level of safety, both functionally and emotionally, and an effective feedback to the patient are obtained.
- the request can e.g. be initiated by a timer or other external events such as the patient performing an action.
- the invention provides the further effect that a patient need not bring along a large apparatus technically complicated in use in order to treat his disease, but that the apparatus may be divided into several smaller and simpler units capable of communicating mutually.
- the individual units may optionally be adapted to be interconnected mechanically, as disclosed in Danish Patent Application No. PA199800714.
- IRQ interrupt request
- a protocol for a self-organizing network where every apparatus retransmits all the received information until the apparatus or apparatuses which the information was meant for receive it. In this way every apparatus functions as a relay station and a temporary store of transmitted information. This structure is especially useful when the configuration of the network is not known or when the configuration of the network changes in an unpredictable manner.
- Another feature of a network of this kind is that a maximal number of redundant transmission paths with a buffer are created so that the system can transmit information to apparatuses which were not available when the information was transmitted.
- the unit of highest priority may be adapted to communicate with a larger communication center which may contain a patient database.
- a larger communication center which may contain a patient database.
- Such further use of the invention is known e.g. from U.S. Pat. No. 5,204,670, which, however, cannot offer the patient the flexible and safe use of a set of different apparatuses according to the invention which together are used in the treatment of a disease.
- the apparatuses according to the invention communicate information such as: amount of medication, type of medication, the concentration of relevant substances in the body e.g. body fluid level/concentration, time stamp, amount of food (e.g. amount or units of carbohydrate), measurement of physical activity, notification (e.g. alert and warning) to the patient, body characteristics (e.g. weight, blood pressure etc.) and inventory logistics.
- information such as: amount of medication, type of medication, the concentration of relevant substances in the body e.g. body fluid level/concentration, time stamp, amount of food (e.g. amount or units of carbohydrate), measurement of physical activity, notification (e.g. alert and warning) to the patient, body characteristics (e.g. weight, blood pressure etc.) and inventory logistics.
- relevant information for e.g. a drug administration system like a doser i.e. number of units of insulin, insulin type and time and date for administering, can automatically be stored, displayed, received and transmitted to and from all the relevant apparatuses.
- the patient, a physician or an expert care-team can obtain the behavior over time of the patient, and a check for compliance to a diet or treatment given to the patient by a physician or an expert care-team can be made. This could also be done automatically.
- the patient may manually input information about the treatment.
- This information may be historic information as well as information about a future scheme (behavioral pattern) e.g. planned physical exercise, administering of insulin, intake of food and other medications.
- This information may be collected and thus serve as an electronic diabetes diary or may be used to notify the patient through the receiving means as to whether the planned actions are dangerous or not.
- the patient can further receive recommended amounts of medication, exercise, food, etc. from a physician, an expert-team or automatically.
- the invention also relates to an apparatus for a medical apparatus for use by a patient for medical self treatment, the treatment including a first operation and at least a second operation, the apparatus comprising a first apparatus for performing the first operation and a second apparatus for performing the second operation, wherein each apparatus comprises means for storing and/or displaying information, and comprising means for transmitting and receiving information so that each apparatus is able to exchange data with any of the other apparatuses belonging to the self treatment.
- the relevant information could be the time and date for measurement, measured level/concentration of blood glucose which could be stored or transmitted to another apparatus.
- the relevant information could be the type of medication (e.g. long acting or short acting insulin), number of units of insulin to be administered and the time and date of the administering. This information could both be set manually by the patient or remotely by a physician, an expert care-team or automatically.
- the relevant information could be to keep track of the contents of the container so that every time an object (e.g. carpoule, needle, etc.) is used, the storage container will update the inventory list.
- This list could be transferred to an unit of highest priority immediately or later, which could in turn update the patient's total holdings of objects, so that the system could notify the patient when he should order a new stock of objects.
- the ordering could also be done automatically by the system if the inventory list is transferred to an external unit, which greatly improves the confidence, comfort and safety of the patient.
- a specific simple communication protocol has been chosen to simplify the explanation of the invention.
- a predefined apparatus is chosen as the unit of highest priority (master module) which controls, coordinates and monitors the mutual data communication between all the apparatuses including itself
- the master module collects or mirrors all the data stored in the other apparatuses. This collected or mirrored data can then be redistributed to any of the other apparatuses or an external unit (e.g. a personal computer or database system ) for later retrieval and/or processing.
- the portable system can operate even if the master module is not present, since all the relevant apparatuses comprise internal storage means, so that they can store the relevant information when it is obtained and transmit it when they can reach the master module once again.
- the information obtained is kept in the apparatuses so that the patient on request always can be presented with the latest measurements and/or information obtained or received.
- a cap unit for a doser has been chosen as the master module but any apparatus could have been chosen just as easily.
- the master module should be the apparatus that the patient carries most often.
- FIG. 1 shows a prior art doser with a conventional cap
- FIG. 2 shows a doser and a cap with a BGM, a lancet device and a container for test strips attached;
- FIG. 3 shows a cap with a BGM, a lancet device, a test strip container attached and an additional container together with useful/needed extras;
- FIG. 4 shows a schematic functional diagram of a BGM according to an embodiment of the invention
- FIG. 5 shows a schematic functional diagram of a doser according to an embodiment of the invention
- FIG. 6 shows a schematic functional diagram of a unit of highest priority according to an embodiment of the invention.
- FIG. 7 shows a flowchart illustrating an apparatus generating new data (e.g. a BGM) and how the apparatus behaves with respect to data generation and communication;
- new data e.g. a BGM
- FIG. 8 illustrates the general concept according to an embodiment of the invention with respect to communication
- FIG. 9 illustrates two dosers and their communication paths.
- FIG. 1 shows a prior art doser 20 and a cap 10 .
- the doser 20 comprises a turning wheel 21 for adjusting, either electronically or manually, the level/amount of medication to be administered, and a display 22 that shows the currently selected amount of medication to be administered.
- the doser 20 has processing means and storage facilities, like a CPU and RAM, for storing data, like the time, date and amount of medication of the last couple of administrations. This information can be shown in the display 22 at request.
- the doser 20 further comprises a carpoule (not shown) that contains the medication, and is fitted with a needle 27 through which the medication is administered.
- the doser 20 has a transparent window 25 so that the amount of medication left in the carpoule can readily be identified.
- the cap 10 can be fitted to the doser 20 so that one single compact unit and protection of the doser 20 , needle 27 , etc. are obtained.
- FIG. 2 shows a doser 20 with a cap 10 where the cap 10 functions as the master module.
- the doser 20 corresponds to the doser 20 shown in FIG. 1 but with the additional feature of having transmitting and receiving means 12 .
- This enables the doser 20 to transmit the stored data, i.e. the time, date, amount and type of medication, to the master module 10 for storage and presentation there via the master modules receiving means 12 .
- Information of the last couple of administrations time, date, type and amount of medication
- the doser 20 will just store the information locally until the master module 10 becomes available and the patient will be able to view the information on the doser 20 .
- the doser 20 can also receive information via the receiving means 12 from the master module 10 .
- This information could for instance be a predetermined amount of medication dictated remotely by a physician, an expert care-team or automatically. The received information is then used to automatically set the correct amount of medication to be administered so that the patient does not have to worry about that aspect, which is a great advantage especially if the patient is elderly or handicapped.
- a BGM 30 which has means 34 for inserting test strips 52 containing a sample of blood, for analysis by the BGM 30 by operating the buttons 36 .
- the result of the analysis is stored and either shown in the display 32 or transmitted to the master module 10 via the transmitting means 12 for storage and presentation on the larger display 11 .
- the patient can at the same time be presented with the last couple of results over a time period.
- a test strip container 50 is provided for the safe keeping/storing of test strips 52 in the space 55 and can be added/attached through locking means 31 . With this addition, a test strip 52 will always be available.
- a lancet device 40 removably attached to the BGM 30 by the locking means 31 .
- This lancet device 40 is used by first loading the lancet device through the grip 44 and then pressing the button 42 , which releases the lancet, piercing the skin, so that a blood sample can be obtained. With this inclusion, the lancet device 40 is always at hand.
- the test strip 52 can then be inserted via the means 34 into the BGM 30 , which will start analysing the blood sample and, after completion of the analysis, will show the result in the display 32 .
- FIG. 3 shows the same units as are shown in FIG. 2, but instead of a doser 20 , there is now provided a container unit 60 with a relative large space 69 for storing the items needed everyday for self-treatment.
- a container unit 60 with a relative large space 69 for storing the items needed everyday for self-treatment.
- such items could be a napkin 61 for wiping excessive blood after a sample has been taken, a waste container 62 for receiving used items, an extra carpoule 63 which could contain another type of insulin, spare needles 27 for the doser, spare lancets 65 for the lancet device 40 , some glucose in the form of glucose tablets 64 , etc.
- the injection of insulin may be replaced by administration of pills which may be stored in the container, which thus replaces the doser described previously. All these items, or the most relevant ones for a given situation, could be held in the container space 69 for easy retrieval, when needed.
- the container unit 60 is provided with transmitting, receiving and storage means 12 . These means are used to communicate an inventory list to the master module 10 on which the user can view and update the inventory list via the buttons 36 .
- This list could be transferred to an external unit (e.g. computer, laptop, palmtop, etc.) immediately or later, which could update a list of the patient's total holdings of objects, so that the system could notify the patient when he should order a new stock of objects.
- the ordering could also be done automatically by the system. In this way the patient will not have to be concerned whether he has all the necessary objects for a future span of time or not, which greatly improves the confidence and safety of the patient.
- FIG. 4 shows a schematic functional diagram of a BGM according to an embodiment of the invention.
- the BGM consists of the following functional blocks: ‘Controller’, ‘Receiving means’, ‘Transmitting means’, ‘storage means’, ‘Displaying means’, ‘Input means’ and ‘Measuring Blood Glucose Level/Concentration’.
- the central block is the functional block ‘Controller’ which coordinates, monitors and controls the tasks of all the other functional blocks.
- the ‘Receiving means’ and ‘Transmitting means’ is responsible for receiving and transmitting of information data, respectively.
- the block ‘Measuring Blood Glucose Level/Concentration’ performs the measurement of the blood glucose level/concentration on e.g. a test strip, containing a blood sample.
- the ‘Displaying means’ can display relevant information to the patient e.g. the result of a measurement and a time stamp containing the time and date of the measurement.
- the result of the measurement can be stored in the ‘storage means’ for later retrieval and further be sent to another apparatus (e.g. the master module) through the ‘Transmitting means’. All these tasks take place under the supervision and coordination of the ‘Controller’ block.
- the BGM could thus be operated in the following way.
- the controller receives the request and activates the ‘Measuring Blood Glucose Level/Concentration’ block, which initiates and performs the measurement of the blood glucose level when the patient inserts a test strip with a sample of blood into a slot on the apparatus.
- a calibration of the measurement equipment could be made by insertion of a calibration test-strip.
- the result and a time stamp of the measurement are then transferred to the storage means, and the controller can send the result via the transmitting means to another device e.g. the master module if it is within range.
- Controller could e.g. be implemented by any type of CPU, micro processor, micro controller, EEPROM or ROM containing software, firmware, etc.
- the functional block ‘storage means’ could be standard RAM.
- the BGM is only an example of an apparatus that could be used according to this invention. Any other body fluid analyser e.g. lipid monitor or the like could be used.
- FIG. 5 shows a schematic functional diagram of a doser according to an embodiment of the invention.
- the doser consists of the following functional blocks: ‘Controller’, ‘Receiving means’, ‘Transmitting means’, ‘storage means’, ‘Displaying means’, ‘Input means’ and ‘Administering a dose of Medication’.
- These functional blocks correspond to the blocks previously described for the BGM in FIG. 4, except for the block ‘Administering a dose of Medication’, and will therefore not be explained once more.
- the functional block ‘Administering a dose of Medication’ administers a dose of medication e.g. insulin.
- the amount of medication could be set by the patient through the ‘Input means’ or be set electromechanically by the ‘Controller’ block according to information received via the ‘Receiving means’. This information could be prescribed by a physician, by an expert care-team or automatically, so that elderly or handicapped people would only have to activate the doser through the input means to be administered a dose of medication.
- information e.g. type of medication (e.g. long acting or short acting insulin), amount of medication and the corresponding time stamp (date and time) is stored in the ‘storage means’ and transmitted to an apparatus (preferably the master module) if it is within range.
- Other devices than an insulin doser could be used in accordance with the invention. These could e.g. be devices that administer growth hormones, etc.
- a predetermined list would require the user to just enter (e.g. by icons or alphanumeric keys) the relevant text once and then later just present the user with the already entered text and only ask for the amount and type (which could also be pre-entered in the same fashion).
- FIG. 6 shows a schematic functional diagram of a master module according to an embodiment of the invention.
- the master module consists of the following functional blocks: ‘Controller’, ‘Receiving means’, ‘Transmitting means’, ‘Storage means’, ‘Displaying means’, ‘Input means’ and ‘External function’. These functional blocks correspond to the blocks previously described with reference to FIGS. 4 and 5, except for the block ‘External function’, and will therefore not be explained once more.
- the master module is the module responsible for the coordination, supervision and control of the information and data exchange between itself and all the other present and activated apparatuses. These apparatuses identify themselves to the master module when they are within range so that the master module always knows which apparatuses are present and activated.
- the master module also receives and stores all the information and data generated in the individual apparatuses for later retrieval and/or transmission to an external unit (e.g. computer or database) for further storage and processing.
- the relevant information can be displayed on the larger display of the master module and be acted upon by the patient.
- the master module could be any of the apparatuses as represented by the functional block ‘External function’ in FIG. 6, but is in this embodiment the cap unit 10 shown in FIGS. 2 - 3 , and has as such no external function. Other functions may readily be implemented in this block.
- FIG. 7 shows a flowchart illustrating an apparatus generating new data (e.g. a BGM) and how the apparatus behaves with respect to data generation and communication.
- new data e.g. a BGM
- the apparatus determines whether or not data generation is requested. If this is the case (e.g., if the user has inserted a blood glucose measuring strip into the apparatus), the data generation block assumes priority and completes the procedures associated with the data generation (e.g. measurement of the blood glucose concentration). After completion of the data generation the data is stored in the internal memory of the apparatus.
- the apparatus determines whether or not communication is requested—either by the apparatus itself (several criteria can issue the communication request e.g. a timing event, a user interface event, etc.) or by an apparatus different from the apparatus itself (e.g. a request from the master module). If communication is not requested, the apparatus resumes its idle mode. If communication is requested, the apparatus sends out a request for the other apparatuses within its range to identify themselves to the apparatus—enabling it to establish the present communication environment. Based on the established communication environment the apparatus identifies whether or not the master module is within range of the apparatus. If the master module is not within range of the apparatus, the communication is terminated and the apparatus returns to its idle mode.
- the apparatus sets up a connection with the master module and identifies itself to the master module. After exchange of apparatus identification it is established whether the master module is updated with respect to the internal data contained in the internal memory of the apparatus or not. If the master module is updated, the data is not transmitted once more. If, however, the master is not updated regarding the internal data of the apparatus, the data necessary to update the master is transmitted from the apparatus to the master module. After completion of the data transmission it is likewise established if the master module contains data relevant to the apparatus which is not present in the apparatus. If this is the case, the master module transmits the relevant data to the receiving means of the apparatus after which the data is stored in the internal memory of the apparatus. After storage of the received data or if no data transmission was necessary, the apparatus returns to its idle mode and the circle is completed.
- FIG. 8 illustrates the general concept according to an embodiment of the invention with respect to communication.
- the system consists of the portable units: a master module, a doser, a BGM, the remote units: Remote Receiver, Physician/Expert Care-team and Stationary Unit and a Communication Interface between them.
- the master module controls the information and data flow between itself and the other apparatuses and collects relevant data and information from all the other portable units.
- This data and information could e.g. be amount of medication, type of medication, body fluid concentration, time stamp (date and time) and inventory logistics.
- the patient can manually input information and data related to amount of food, measurement of physical activity in the way described above.
- This data and information can then be transmitted via a communication interface (which may be built into the master module) to external units like a database for data acquisition of the patient's data over time or a computer which the patient uses to be kept informed about his treatment.
- all the apparatuses could communicate to all the others.
- the information in the database can be accessed by a physician or an expert care-team who could easily and quickly check for compliance to e.g. a diet or treatment course/progress.
- the physician or expert care-team could send a notification (e.g. alert or warning) to the patient if the data shows an inappropriate future treatment span.
- the patient could also be notified of a future appointment in this way or receive guidance.
- the system also makes it possible for the physician or expert care-team to give the patient a number of choices to a given situation.
- the patient could e.g. be informed that the blood glucose level/concentration is quite high and the patient could be presented with the choices of either exercising for given amount of time or administering a given amount of a given type of medication.
- the possibility of choices makes the patient feet more in control of the treatment and enhances the therapeutic value of the treatment. This could also be done automatically be the systems.
- FIG. 9 illustrates two dosers and their communication paths
- the dosers are identical for the typical patient, one doser containing fast acting insulin, the other doser containing slow acting insulin.
- the dosers comprise a microcontroller and memory as shown in FIG. 5.
- the dosers are capable of holding information about the insulin type they contain. This information may either be obtained by the doser reading e.g. a bar code on the carpoule or the information may be input from the patient.
- the features of the doser enable it to log information about the insulin treatment (insulin type size of the dose and time stamp)
- One doser is equipped with a cap unit 73 which acts as a storage container for an extra insulin carpoule, needles etc.
- the storage container is capable of keeping track of the contents of the container which enables it to keep the inventory list updated, as described earlier in the present document.
- the other doser is equipped with a cap unit 74 comprising a BGM, a microcontroller and memory . This enables the cap unit 74 to log information about the blood glucose concentration (with time stamp).
- All the dosers 71 , 72 and the cap units 73 , 74 comprise an interface which enables them to exchange data.
- the master device is the BGM cap unit 74 , which, in addition to the local interface, comprises an interface that enables it to communicate with external units through standard communication links (RS-232, Wireless local area network, phone, cellular phone, pager, satellite link, etc.).
- standard communication links RS-232, Wireless local area network, phone, cellular phone, pager, satellite link, etc.
- the patient's treatment data can be transferred to the patient's own computer 80 or via e.g. the telephone system 75 to the patient's electronic medical record on a central server 76 . From here, the treatment data may be accessed by the patient e.g.
- the care team can access the patient's treatment data.
- the patient's master unit 74 can receive data from the central server 76 , in addition to transmitting data.
- the treatment data are transferred to the master unit 74 , enabling it to supply the patient with a overview of his treatment as well as warnings or alarms if data shows that a potential dangerous situation may occur.
Abstract
This invention relates to an system for self treatment. The system consists of several portable modules where one of the modules is designated as a master module. The master module controls, supervises and monitors all the mutual information and data exchange between itself and the rest of the modules. The modules can e.g. consist of a BGM, a doser and a storage container. The modules may be able to generate and store data which is transmitted to the master module if it is within range. If the master module is not within range, the data is kept locally in the module until the master module is available. The master module can send the data to an external unit like a computer or database for further processing. A physician or an expert care-team can access the data in the database and give guidance to the patient on the basis of these processed data. This processing could also be done automatically by utilization of an expert system.
Description
- This application claims priority under 35 U. S. C. 119 of U.S. non provisional application No. 09/450,193 filed Nov. 29, 1999 and provisional application No. 60/111,721 filed Dec. 9, 1998 and Danish Application No. PA 1998 01578 filed Nov. 30, 1998; the contents of all three are fully incorporated herein by reference.
- This invention comprises a medical system and a method of controlling the system for use by a patient for medical self treatment.
- For a number of years it has been possible to purchase various devices for the treatment of diabetes, e.g. for injecting insulin, for measuring blood sugar (such a device is referred to as BGM in the following), for withdrawing blood samples, and other accessories, the purpose of which is to enable the patient to nurse his disease discretely and with a high standard of safety. Many diabetic patients are elderly people who can easily get insecure with respect to the medical equipment. It is very reassuring and therefore also very important that the user can have feedback from the system which confirms to the user that everything is OK right from the technical function of the system to the patient's physiological condition. This stretches out a psychological safety net under the patient, which contributes to improving the quality of life of patients having a disease such as diabetes.
- Also many young people need to assure themselves that the equipment is in order, i.e. calibrated, powered, updated and otherwise ready to be operated.
- One way of ensuring that you have all the things needed ready at hand is to build several of the necessary devices together into a single integral unit, see e.g. U.S. Pat. No. 5,536,249. This is not an ideal solution since such a multi-functional device is usually quite complex both with respect to manufacture and use. People need to be familiar, secure and confident with the use of a device for self-treatment which such an integral multi-functional does not provide.
- Another drawback of integrating several functions in one apparatus is that owing to the commercial outlets the manufacturer never integrates all possibilities, but just the most important ones, in order for it to be relevant to a sufficiently large group of users. The functions which are thus not integrated must be provided by means of separate apparatuses typically of different makes, which can easily create uncertainty as to whether the apparatuses work correctly together.
- According to the invention the individual devices may be arranged for various respective functions relevant to the treatment of e.g. diabetes, such as: a lancet device, a body fluid analyser, one or more drug administration apparatuses for administering a predetermined dose of medication to the patient. Further, there is a number of other aids which the diabetic patient uses, e.g. test strips for the blood analyser, needles, napkins for wiping off blood, extra insulin carpoule, glucose tablets, waste containers, etc.
- The object of the invention is to provide a method for effective monitoring of electronic data relevant to a plurality of apparatuses which are used by a patient for self-treatment of a disease, so that a greater level of safety, both functionally and emotionally, and an effective feedback to the patient are obtained.
- This is achieved according to the invention in that the individual apparatuses are provided with electronic communications equipment so that the apparatuses—when in a state of mutual communication—frequently exchange information between them. Hereby a greater functional safety can be achieved and the total data capacity of the system can be increased, so that the feedback possibilities, e.g. of the system checking that every apparatus is OK and set up properly and of the patient be given a number of possible choices to choose from in a given situation, are increased.
- More particularly, the invention relates to a method of controlling data information between a plurality of portable apparatuses for use by a patient for medical self treatment, the treatment including a first operation and at least a second operation, said portable apparatuses comprising a first apparatus for performing the first operation, and at least a second apparatus for performing the second operation, wherein each apparatus belonging to the medical self treatment has means for one or more of the following: storing, transmitting, receiving and displaying information, and an attempted data communication between said apparatuses is initiated on request.
- The request can e.g. be initiated by a timer or other external events such as the patient performing an action.
- The invention provides the further effect that a patient need not bring along a large apparatus technically complicated in use in order to treat his disease, but that the apparatus may be divided into several smaller and simpler units capable of communicating mutually. The individual units may optionally be adapted to be interconnected mechanically, as disclosed in Danish Patent Application No. PA199800714.
- According to the invention, all apparatuses need not be active for communication to be established between some of the apparatuses. This requires that all the apparatuses are adapted to a specific communications protocol, there being several options in this respect. For example, one of the units may be provided with program information of highest priority with respect to the control and monitoring of data communication between the individual apparatuses. The unit of highest priority may very well be turned off, because the apparatuses may be adapted to communicate directly and perform storage of information, which is subsequently transmitted to the unit of highest priority when this is again in communication with another of the apparatuses.
- Alternatively, other communications protocols may be implemented such as:
- A protocol where a number of potential master modules (unit of highest priority) is predefined. These predefined master modules are given a hierarchical priority and the master module with the highest priority among the activated and present master modules becomes the functional master module. This master module polls the other activated and present apparatuses for information.
- A protocol where all the apparatuses can request information/data exchange with one or more of the other possible apparatuses (present and activated) on the basis of an event (e.g. timer based, user operation, etc.). This is done by sending an interrupt request (IRQ) to the other apparatuses which they can act upon according to their situation. With this protocol there is not a designated master module and every apparatus can communicate/exchange data with one or more of the rest of the apparatuses.
- A protocol for a self-organizing network where every apparatus retransmits all the received information until the apparatus or apparatuses which the information was meant for receive it. In this way every apparatus functions as a relay station and a temporary store of transmitted information. This structure is especially useful when the configuration of the network is not known or when the configuration of the network changes in an unpredictable manner. Another feature of a network of this kind is that a maximal number of redundant transmission paths with a buffer are created so that the system can transmit information to apparatuses which were not available when the information was transmitted.
- A protocol where all the apparatuses transmits their information without any supervision of any kind. The apparatuses themselves have to decide what information is relevant for them.
- The unit of highest priority may be adapted to communicate with a larger communication center which may contain a patient database. Such further use of the invention is known e.g. from U.S. Pat. No. 5,204,670, which, however, cannot offer the patient the flexible and safe use of a set of different apparatuses according to the invention which together are used in the treatment of a disease.
- The apparatuses according to the invention communicate information such as: amount of medication, type of medication, the concentration of relevant substances in the body e.g. body fluid level/concentration, time stamp, amount of food (e.g. amount or units of carbohydrate), measurement of physical activity, notification (e.g. alert and warning) to the patient, body characteristics (e.g. weight, blood pressure etc.) and inventory logistics. This ensures that relevant information for e.g. a drug administration system like a doser, i.e. number of units of insulin, insulin type and time and date for administering, can automatically be stored, displayed, received and transmitted to and from all the relevant apparatuses. The doser could also receive information regarding a predetermined number of units of insulin to be administered and automatically set the amount of medication to be administered by electromechanical means. In this way elderly and handicapped people do not have to set the relevant amount of medication themselves but just activate the doser.
- It is especially useful to transmit the data from all apparatuses to the apparatus containing the highest priority program for safe keeping, calibration and updating of data and possible transmission to e.g. an external unit like a PC or database for further data acquisition, storage and processing.
- In this way the patient, a physician or an expert care-team can obtain the behavior over time of the patient, and a check for compliance to a diet or treatment given to the patient by a physician or an expert care-team can be made. This could also be done automatically.
- Additionally, it is also possible for the patient to manually input information about the treatment. This information may be historic information as well as information about a future scheme (behavioral pattern) e.g. planned physical exercise, administering of insulin, intake of food and other medications. This information may be collected and thus serve as an electronic diabetes diary or may be used to notify the patient through the receiving means as to whether the planned actions are dangerous or not.
- It is evident that since the apparatuses are to be carried by the patient, there is a potential lack of space for an advanced input device e.g. a keyboard. Therefore, information which cannot be input on a standardized form e.g. personal comments on the treatment is typed into the apparatus by the patient using a simple input device once and can subsequently be chosen from a list if needed again.
- The patient can further receive recommended amounts of medication, exercise, food, etc. from a physician, an expert-team or automatically.
- The invention also relates to an apparatus for a medical apparatus for use by a patient for medical self treatment, the treatment including a first operation and at least a second operation, the apparatus comprising a first apparatus for performing the first operation and a second apparatus for performing the second operation, wherein each apparatus comprises means for storing and/or displaying information, and comprising means for transmitting and receiving information so that each apparatus is able to exchange data with any of the other apparatuses belonging to the self treatment.
- For a BGM according to an embodiment of the invention the relevant information could be the time and date for measurement, measured level/concentration of blood glucose which could be stored or transmitted to another apparatus.
- For a doser according to an embodiment of the invention the relevant information could be the type of medication (e.g. long acting or short acting insulin), number of units of insulin to be administered and the time and date of the administering. This information could both be set manually by the patient or remotely by a physician, an expert care-team or automatically.
- For a storage container according to an embodiment of the invention the relevant information could be to keep track of the contents of the container so that every time an object (e.g. carpoule, needle, etc.) is used, the storage container will update the inventory list. This list could be transferred to an unit of highest priority immediately or later, which could in turn update the patient's total holdings of objects, so that the system could notify the patient when he should order a new stock of objects. The ordering could also be done automatically by the system if the inventory list is transferred to an external unit, which greatly improves the confidence, comfort and safety of the patient.
- In the following, a preferred embodiment according to the invention is described in detail. This particular embodiment is meant as one example only of the invention and should not as such limit the scope of protection.
- In the preferred embodiment a specific simple communication protocol has been chosen to simplify the explanation of the invention. In the chosen protocol a predefined apparatus is chosen as the unit of highest priority (master module) which controls, coordinates and monitors the mutual data communication between all the apparatuses including itself The master module collects or mirrors all the data stored in the other apparatuses. This collected or mirrored data can then be redistributed to any of the other apparatuses or an external unit (e.g. a personal computer or database system ) for later retrieval and/or processing.
- According to the invention the portable system can operate even if the master module is not present, since all the relevant apparatuses comprise internal storage means, so that they can store the relevant information when it is obtained and transmit it when they can reach the master module once again.
- Preferably the information obtained is kept in the apparatuses so that the patient on request always can be presented with the latest measurements and/or information obtained or received.
- A person skilled in the art could easily implement other communication protocols such as the ones described above.
- In this embodiment a cap unit for a doser has been chosen as the master module but any apparatus could have been chosen just as easily. Preferably, the master module should be the apparatus that the patient carries most often.
- The invention will now be explained in detail with reference to the FIGS.1-9, in which
- FIG. 1 shows a prior art doser with a conventional cap;
- FIG. 2 shows a doser and a cap with a BGM, a lancet device and a container for test strips attached;
- FIG. 3 shows a cap with a BGM, a lancet device, a test strip container attached and an additional container together with useful/needed extras;
- FIG. 4 shows a schematic functional diagram of a BGM according to an embodiment of the invention;
- FIG. 5 shows a schematic functional diagram of a doser according to an embodiment of the invention;
- FIG. 6 shows a schematic functional diagram of a unit of highest priority according to an embodiment of the invention;
- FIG. 7 shows a flowchart illustrating an apparatus generating new data (e.g. a BGM) and how the apparatus behaves with respect to data generation and communication;
- FIG. 8 illustrates the general concept according to an embodiment of the invention with respect to communication;
- FIG. 9 illustrates two dosers and their communication paths.
- FIG. 1 shows a
prior art doser 20 and acap 10. Thedoser 20 comprises aturning wheel 21 for adjusting, either electronically or manually, the level/amount of medication to be administered, and adisplay 22 that shows the currently selected amount of medication to be administered. Thedoser 20 has processing means and storage facilities, like a CPU and RAM, for storing data, like the time, date and amount of medication of the last couple of administrations. This information can be shown in thedisplay 22 at request. Thedoser 20 further comprises a carpoule (not shown) that contains the medication, and is fitted with aneedle 27 through which the medication is administered. Thedoser 20 has atransparent window 25 so that the amount of medication left in the carpoule can readily be identified. Thecap 10 can be fitted to thedoser 20 so that one single compact unit and protection of thedoser 20,needle 27, etc. are obtained. - FIG. 2 shows a
doser 20 with acap 10 where thecap 10 functions as the master module. Thedoser 20 corresponds to thedoser 20 shown in FIG. 1 but with the additional feature of having transmitting and receiving means 12. This enables thedoser 20 to transmit the stored data, i.e. the time, date, amount and type of medication, to themaster module 10 for storage and presentation there via the mastermodules receiving means 12. Information of the last couple of administrations (time, date, type and amount of medication) can then easily be viewed on thedisplay 11 on the master module. If themaster module 10 is not present or active, thedoser 20 will just store the information locally until themaster module 10 becomes available and the patient will be able to view the information on thedoser 20. - The
doser 20 can also receive information via the receiving means 12 from themaster module 10. This information could for instance be a predetermined amount of medication dictated remotely by a physician, an expert care-team or automatically. The received information is then used to automatically set the correct amount of medication to be administered so that the patient does not have to worry about that aspect, which is a great advantage especially if the patient is elderly or handicapped. - Also shown is a
BGM 30 which has means 34 for insertingtest strips 52 containing a sample of blood, for analysis by theBGM 30 by operating thebuttons 36. The result of the analysis is stored and either shown in thedisplay 32 or transmitted to themaster module 10 via the transmitting means 12 for storage and presentation on thelarger display 11. The patient can at the same time be presented with the last couple of results over a time period. - A
test strip container 50 is provided for the safe keeping/storing oftest strips 52 in thespace 55 and can be added/attached through locking means 31. With this addition, atest strip 52 will always be available. - Further shown is a
lancet device 40 removably attached to theBGM 30 by the locking means 31. Thislancet device 40 is used by first loading the lancet device through thegrip 44 and then pressing thebutton 42, which releases the lancet, piercing the skin, so that a blood sample can be obtained. With this inclusion, thelancet device 40 is always at hand. This has the advantage that alancet device 40 is always available, for taking a blood sample and applying it to atest strip 52. Thetest strip 52 can then be inserted via themeans 34 into theBGM 30, which will start analysing the blood sample and, after completion of the analysis, will show the result in thedisplay 32. It is very useful to have theBGM 30 and thelancet device 40 attached together in one compact unit, since aBGM 30 would not normally be used without thelancet device 40, thereby avoiding the fuss and uncertainty of using multiple devices of perhaps different makes. On the other hand, if the user already has a lancet device and is accustomed to and familiar with the use of this particular lancet device, he can still use this original lancet device and just use the remaining items, which will be a compact set consisting of adoser 20 and aBGM 30; The cost will be reduced hereby. - FIG. 3 shows the same units as are shown in FIG. 2, but instead of a
doser 20, there is now provided acontainer unit 60 with a relativelarge space 69 for storing the items needed everyday for self-treatment. For a diabetic, e.g. such items could be anapkin 61 for wiping excessive blood after a sample has been taken, awaste container 62 for receiving used items, anextra carpoule 63 which could contain another type of insulin,spare needles 27 for the doser,spare lancets 65 for thelancet device 40, some glucose in the form ofglucose tablets 64, etc. In some situations and in certain forms of diabetes, the injection of insulin may be replaced by administration of pills which may be stored in the container, which thus replaces the doser described previously. All these items, or the most relevant ones for a given situation, could be held in thecontainer space 69 for easy retrieval, when needed. - The
container unit 60 is provided with transmitting, receiving and storage means 12. These means are used to communicate an inventory list to themaster module 10 on which the user can view and update the inventory list via thebuttons 36. - This list could be transferred to an external unit (e.g. computer, laptop, palmtop, etc.) immediately or later, which could update a list of the patient's total holdings of objects, so that the system could notify the patient when he should order a new stock of objects. The ordering could also be done automatically by the system. In this way the patient will not have to be concerned whether he has all the necessary objects for a future span of time or not, which greatly improves the confidence and safety of the patient.
- FIG. 4 shows a schematic functional diagram of a BGM according to an embodiment of the invention. The BGM consists of the following functional blocks: ‘Controller’, ‘Receiving means’, ‘Transmitting means’, ‘storage means’, ‘Displaying means’, ‘Input means’ and ‘Measuring Blood Glucose Level/Concentration’.
- The central block is the functional block ‘Controller’ which coordinates, monitors and controls the tasks of all the other functional blocks. The ‘Receiving means’ and ‘Transmitting means’ is responsible for receiving and transmitting of information data, respectively. The block ‘Measuring Blood Glucose Level/Concentration’ performs the measurement of the blood glucose level/concentration on e.g. a test strip, containing a blood sample. The ‘Displaying means’ can display relevant information to the patient e.g. the result of a measurement and a time stamp containing the time and date of the measurement. The result of the measurement can be stored in the ‘storage means’ for later retrieval and further be sent to another apparatus (e.g. the master module) through the ‘Transmitting means’. All these tasks take place under the supervision and coordination of the ‘Controller’ block.
- The BGM according to an embodiment of the invention could thus be operated in the following way. When a request for a measurement of the blood glucose level/concentration is made either by the patient through the ‘Input means’ or by another apparatus through the ‘Receiving means’, the controller receives the request and activates the ‘Measuring Blood Glucose Level/Concentration’ block, which initiates and performs the measurement of the blood glucose level when the patient inserts a test strip with a sample of blood into a slot on the apparatus. Previously a calibration of the measurement equipment could be made by insertion of a calibration test-strip. The result and a time stamp of the measurement are then transferred to the storage means, and the controller can send the result via the transmitting means to another device e.g. the master module if it is within range.
- All these functional blocks could be implemented by prior art/standard components. The block labeled ‘Controller’ could e.g. be implemented by any type of CPU, micro processor, micro controller, EEPROM or ROM containing software, firmware, etc. The functional block ‘storage means’ could be standard RAM.
- The BGM is only an example of an apparatus that could be used according to this invention. Any other body fluid analyser e.g. lipid monitor or the like could be used.
- FIG. 5 shows a schematic functional diagram of a doser according to an embodiment of the invention. The doser consists of the following functional blocks: ‘Controller’, ‘Receiving means’, ‘Transmitting means’, ‘storage means’, ‘Displaying means’, ‘Input means’ and ‘Administering a dose of Medication’. These functional blocks correspond to the blocks previously described for the BGM in FIG. 4, except for the block ‘Administering a dose of Medication’, and will therefore not be explained once more.
- The functional block ‘Administering a dose of Medication’ administers a dose of medication e.g. insulin. The amount of medication could be set by the patient through the ‘Input means’ or be set electromechanically by the ‘Controller’ block according to information received via the ‘Receiving means’. This information could be prescribed by a physician, by an expert care-team or automatically, so that elderly or handicapped people would only have to activate the doser through the input means to be administered a dose of medication. After the activation of the doser, information e.g. type of medication (e.g. long acting or short acting insulin), amount of medication and the corresponding time stamp (date and time) is stored in the ‘storage means’ and transmitted to an apparatus (preferably the master module) if it is within range.
- Other devices than an insulin doser could be used in accordance with the invention. These could e.g. be devices that administer growth hormones, etc. One could also have an device that obtains information of orally obtained medication like OHA (Oral Hyperglychemical Agent). This would, however, require the user to manually input the type and amount of medication, which could be done by choosing icons, selecting an object in a predetermined list or typing the information by alphanumeric keys. Preferably, a predetermined list would require the user to just enter (e.g. by icons or alphanumeric keys) the relevant text once and then later just present the user with the already entered text and only ask for the amount and type (which could also be pre-entered in the same fashion).
- FIG. 6 shows a schematic functional diagram of a master module according to an embodiment of the invention. The master module consists of the following functional blocks: ‘Controller’, ‘Receiving means’, ‘Transmitting means’, ‘Storage means’, ‘Displaying means’, ‘Input means’ and ‘External function’. These functional blocks correspond to the blocks previously described with reference to FIGS. 4 and 5, except for the block ‘External function’, and will therefore not be explained once more.
- The master module is the module responsible for the coordination, supervision and control of the information and data exchange between itself and all the other present and activated apparatuses. These apparatuses identify themselves to the master module when they are within range so that the master module always knows which apparatuses are present and activated. The master module also receives and stores all the information and data generated in the individual apparatuses for later retrieval and/or transmission to an external unit (e.g. computer or database) for further storage and processing. The relevant information can be displayed on the larger display of the master module and be acted upon by the patient.
- Some of the tasks of the master module could be implemented in the external unit and vice versa.
- The master module could be any of the apparatuses as represented by the functional block ‘External function’ in FIG. 6, but is in this embodiment the
cap unit 10 shown in FIGS. 2-3, and has as such no external function. Other functions may readily be implemented in this block. - FIG. 7 shows a flowchart illustrating an apparatus generating new data (e.g. a BGM) and how the apparatus behaves with respect to data generation and communication.
- In idle mode the apparatus determines whether or not data generation is requested. If this is the case (e.g., if the user has inserted a blood glucose measuring strip into the apparatus), the data generation block assumes priority and completes the procedures associated with the data generation (e.g. measurement of the blood glucose concentration). After completion of the data generation the data is stored in the internal memory of the apparatus.
- After completion of the data generation or after determination that data generation was not requested, the apparatus determines whether or not communication is requested—either by the apparatus itself (several criteria can issue the communication request e.g. a timing event, a user interface event, etc.) or by an apparatus different from the apparatus itself (e.g. a request from the master module). If communication is not requested, the apparatus resumes its idle mode. If communication is requested, the apparatus sends out a request for the other apparatuses within its range to identify themselves to the apparatus—enabling it to establish the present communication environment. Based on the established communication environment the apparatus identifies whether or not the master module is within range of the apparatus. If the master module is not within range of the apparatus, the communication is terminated and the apparatus returns to its idle mode. If however, the master module is within range of the apparatus, the apparatus sets up a connection with the master module and identifies itself to the master module. After exchange of apparatus identification it is established whether the master module is updated with respect to the internal data contained in the internal memory of the apparatus or not. If the master module is updated, the data is not transmitted once more. If, however, the master is not updated regarding the internal data of the apparatus, the data necessary to update the master is transmitted from the apparatus to the master module. After completion of the data transmission it is likewise established if the master module contains data relevant to the apparatus which is not present in the apparatus. If this is the case, the master module transmits the relevant data to the receiving means of the apparatus after which the data is stored in the internal memory of the apparatus. After storage of the received data or if no data transmission was necessary, the apparatus returns to its idle mode and the circle is completed.
- FIG. 8 illustrates the general concept according to an embodiment of the invention with respect to communication. Here the system consists of the portable units: a master module, a doser, a BGM, the remote units: Remote Receiver, Physician/Expert Care-team and Stationary Unit and a Communication Interface between them.
- The master module controls the information and data flow between itself and the other apparatuses and collects relevant data and information from all the other portable units. This data and information could e.g. be amount of medication, type of medication, body fluid concentration, time stamp (date and time) and inventory logistics. Additionally, the patient can manually input information and data related to amount of food, measurement of physical activity in the way described above. This data and information can then be transmitted via a communication interface (which may be built into the master module) to external units like a database for data acquisition of the patient's data over time or a computer which the patient uses to be kept informed about his treatment. Alternatively, all the apparatuses could communicate to all the others.
- The information in the database can be accessed by a physician or an expert care-team who could easily and quickly check for compliance to e.g. a diet or treatment course/progress. The physician or expert care-team could send a notification (e.g. alert or warning) to the patient if the data shows an inappropriate future treatment span. The patient could also be notified of a future appointment in this way or receive guidance.
- The system also makes it possible for the physician or expert care-team to give the patient a number of choices to a given situation. The patient could e.g. be informed that the blood glucose level/concentration is quite high and the patient could be presented with the choices of either exercising for given amount of time or administering a given amount of a given type of medication. The possibility of choices makes the patient feet more in control of the treatment and enhances the therapeutic value of the treatment. This could also be done automatically be the systems.
- Many of the above tasks could be fully automated by utilization of an expert system which is fully updated with the patient's data and condition and has access to the patient's behavior over time.
- FIG. 9 illustrates two dosers and their communication paths The dosers are identical for the typical patient, one doser containing fast acting insulin, the other doser containing slow acting insulin. The dosers comprise a microcontroller and memory as shown in FIG. 5. The dosers are capable of holding information about the insulin type they contain. This information may either be obtained by the doser reading e.g. a bar code on the carpoule or the information may be input from the patient. Thus the features of the doser enable it to log information about the insulin treatment (insulin type size of the dose and time stamp)
- One doser is equipped with a
cap unit 73 which acts as a storage container for an extra insulin carpoule, needles etc. The storage container is capable of keeping track of the contents of the container which enables it to keep the inventory list updated, as described earlier in the present document. - The other doser is equipped with a
cap unit 74 comprising a BGM, a microcontroller and memory . This enables thecap unit 74 to log information about the blood glucose concentration (with time stamp). - All the
dosers cap units BGM cap unit 74, which, in addition to the local interface, comprises an interface that enables it to communicate with external units through standard communication links (RS-232, Wireless local area network, phone, cellular phone, pager, satellite link, etc.). Through these communication links, the patient's treatment data can be transferred to the patient'sown computer 80 or via e.g. thetelephone system 75 to the patient's electronic medical record on acentral server 76. From here, the treatment data may be accessed by the patient e.g. from a web page, using astationary computer 77, alaptop computer 78, ahandheld computer 79, etc. Apart from the patient, the care team can access the patient's treatment data. The patient'smaster unit 74 can receive data from thecentral server 76, in addition to transmitting data. - This system has the advantage that the system can function on 3 levels:
- 1) If one of the patient's
devices - 2) When the patient's
devices master unit 74, enabling it to supply the patient with a overview of his treatment as well as warnings or alarms if data shows that a potential dangerous situation may occur. - 3) When the
master device 74 is connected to thecentral server 76 through standard communication links, the treatment data is transferred to the patient's electronic medical record. This enables an expert system on the central server to notify the care team if needed. The care team may send information back to the user or send help if needed. - Furthermore it is well known that due to the safety of the patient, the development of a medical device is a time consuming task. Using a local communication form between the patient's
devices master device 74 need to be redesigned to keep up with the continuous change in the standard communication links.
Claims (32)
1. A method of controlling data information between a plurality of portable apparatuses for use by a patient for medical self treatment, the treatment including a first operation and at least a second operation, said portable apparatuses comprising a first apparatus for performing the first operation, and at least a second apparatus for performing the second operation, characterized in
that each apparatus belonging to the medical self treatment has means for one or more of the following: storing, transmitting, receiving and displaying information, and
that an attempted data communication between said apparatuses is initiated on request.
2. A method according to claim 1 , characterized in that program information having the highest priority with respect to control and monitoring of mutual data communication between said apparatuses is stored in one of said apparatuses.
3. A method according to claim 2 , characterized in that said data communication is performed as data polling.
4. A method according to claim 2 or 3, characterized in that said program information of highest priority is stored in the apparatus which the patient most often carries.
5. A method according to claims 1-4, characterized in that said means are preadjusted to handle a common set of predetermined measuring and information representations.
6. A method according to claim 5 , characterized in that one or more of said representations from said common set of measuring and information representations are stored in said apparatuses and communicated to said apparatus comprising program information of highest priority when said apparatus comprising program information is within range and ready for communication.
7. A method according to claim 5 or 6, characterized in that said common set of measuring and information representations is stored as one or more of the following representations:
amount of medication
type of medication
body fluid concentration
time stamp
amount of food
measurement of physical activity
notification
inventory logistics
body characteristics (e.g. weight, blood pressure).
8. A method according to claim 7 , characterized in that said common set of measuring and information representations relates to one or more of the following medications
insulin
growth hormones
OHA (Oral Hyperglychemical Agent)
HRT (Hormone Replacement Therapy).
9. A method according to any one of the previous claims, characterized in that said program information of highest priority controls storing, transmitting, receiving and/or displaying information from/to an external unit.
10. A method according to claim 9 , characterized in that said external unit is a computer.
11. A method according to claim 9 , characterized in that said external unit is a database.
12. A medical system for use by a patient for medical self treatment, the treatment including a first operation and at least a second operation, the system comprising a first apparatus for performing the first operation and a second apparatus for performing the second operation, characterized in that each apparatus comprises means for storing and/or displaying information, and comprising means for transmitting and receiving of information so that each apparatus is able to exchange data with any of the other apparatuses belonging to the self treatment.
13. A medical system according to claim 12 , characterized in that one of said apparatuses comprises program information having the highest priority with respect to control and monitoring of mutual data communication between said apparatuses.
14. A medical system according to claim 12 , characterized in that said apparatus comprising program information of highest priority comprises means for storing, transmitting, receiving and/or displaying transmitted information from the other apparatuses.
15. A medical system according to claims 12-14, characterized in that said means are preadjusted to handle a common set of measuring and information representations.
16. A medical system according to claim 15 , characterized in that said apparatuses comprise storing means for storing one or more representations from said common set of measuring and information representations when said apparatus comprising program information of highest priority is out of range for communication.
17. A medical system according to claim 16 , characterized in that said common set of measuring and information representations comprises one or more of the following representations:
amount of medication
type of medication
body fluid concentration
time stamp
amount of food
measurement of physical activity
notification
inventory logistics
body characteristics.
18. A medical system according to claim 17 , characterized in that said common set of measuring and information representations relates to one or more of the following medication:
insulin
growth hormones
OHA (Oral Hyperglychemical Agent)
HRT (Hormone Replacement therapy).
19. A medical system according to claim 13 or 14, characterized in that said apparatus comprising program information of highest priority comprises means for storing, transmitting, receiving and/or displaying information from/to an external unit.
20. A medical system according to claim 19 , characterized in that said external unit is a computer.
21. A medical system according to claim 20 , characterized in that said external unit is a database.
22. A medical system according to any one of the previous claims, characterized in that said first and second apparatuses are selected from the group of
a lancet device
a body fluid analyser
a drug administration system for administering, a predetermined dose of medication to the patient
a sensor for obtaining body characteristics.
23. A medical system according to claim 17 or 22, characterized in that said body fluid concentration is the blood glucose concentration.
24. A medical system according to claim 22 or 23, characterized in that said body fluid analyser is a blood glucose monitor.
25. A medical system according to claim 22 , characterized in that said body fluid analyser is a lipid monitor.
26. A medical system according to claim 22 , characterized in that said body characteristics is one or more of body weight and blood pressure.
27. A medical system according to claim 22 , characterized in that said drug administration system is an insulin injecting device.
28. A medical system according to any one of claims 23-27, characterized in that said apparatus has one or more storage containers for storing a supply of one of more of the following:
a supply of lancets for the body fluid analyser or blood glucose monitor
a supply of test strips for the body fluid analyser or blood glucose monitor
an extra supply (carpoule) of insulin
a supply of needles.
29. A medical system according to claim 24 , characterized in that said blood glucose monitor comprises storing, transmitting and/or displaying means for blood glucose level and/or time stamp.
30. A medical system according to claim 27 , characterized in that said insulin injecting device comprises storing, transmitting, receiving and/or displaying means for a number of units of medication, type of medication and/or time stamp.
31. A medical system according to claim 28 , characterized in that said one or more storage containers comprise storing, transmitting, receiving and/or displaying means for inventory logistics.
32. A medical system according to any one of the previous claims, characterized in that said system comprises means for presentation of choices to the patient for a given situation, said presentation being dependent on said patient's previous choices.
Priority Applications (2)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US10/342,150 US20040039255A1 (en) | 1998-11-30 | 2003-01-14 | Medical system and a method of controlling the system for use by a patient for medical self treatment |
US11/846,028 US20070293742A1 (en) | 1998-11-30 | 2007-08-28 | Medical System And A Method Of Controlling The System For Use By A Patient For Medical Self Treatment |
Applications Claiming Priority (5)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
DKPA199801578 | 1998-11-30 | ||
DKPA199801578 | 1998-11-30 | ||
US11172198P | 1998-12-09 | 1998-12-09 | |
US09/450,193 US6540672B1 (en) | 1998-12-09 | 1999-11-29 | Medical system and a method of controlling the system for use by a patient for medical self treatment |
US10/342,150 US20040039255A1 (en) | 1998-11-30 | 2003-01-14 | Medical system and a method of controlling the system for use by a patient for medical self treatment |
Related Parent Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
US09/450,193 Continuation US6540672B1 (en) | 1998-11-30 | 1999-11-29 | Medical system and a method of controlling the system for use by a patient for medical self treatment |
Related Child Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
US11/846,028 Continuation US20070293742A1 (en) | 1998-11-30 | 2007-08-28 | Medical System And A Method Of Controlling The System For Use By A Patient For Medical Self Treatment |
Publications (1)
Publication Number | Publication Date |
---|---|
US20040039255A1 true US20040039255A1 (en) | 2004-02-26 |
Family
ID=26809167
Family Applications (2)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
US09/450,193 Expired - Lifetime US6540672B1 (en) | 1998-11-30 | 1999-11-29 | Medical system and a method of controlling the system for use by a patient for medical self treatment |
US10/342,150 Abandoned US20040039255A1 (en) | 1998-11-30 | 2003-01-14 | Medical system and a method of controlling the system for use by a patient for medical self treatment |
Family Applications Before (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
US09/450,193 Expired - Lifetime US6540672B1 (en) | 1998-11-30 | 1999-11-29 | Medical system and a method of controlling the system for use by a patient for medical self treatment |
Country Status (1)
Country | Link |
---|---|
US (2) | US6540672B1 (en) |
Cited By (79)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US20050182306A1 (en) * | 2004-02-17 | 2005-08-18 | Therasense, Inc. | Method and system for providing data communication in continuous glucose monitoring and management system |
US20050182358A1 (en) * | 2003-11-06 | 2005-08-18 | Veit Eric D. | Drug delivery pen with event notification means |
WO2006021566A2 (en) * | 2004-08-24 | 2006-03-02 | Novo Nordisk A/S | Giving a service to a patient |
US7072738B2 (en) | 2001-04-02 | 2006-07-04 | Glaxo Group Limited | Medicament dispenser |
US20060231109A1 (en) * | 2004-12-20 | 2006-10-19 | Howell Thomas A | Personal and portable bottle |
US20060279431A1 (en) * | 2005-06-08 | 2006-12-14 | Agamatrix, Inc. | Data collection system and interface |
US20070078818A1 (en) * | 2005-06-09 | 2007-04-05 | Roche Diagnostics Operations, Inc. | Device and method for insulin dosing |
US20070142767A1 (en) * | 2005-12-12 | 2007-06-21 | Marcel Frikart | System with A Portable Patient Device and External Operating Part |
US20070225578A1 (en) * | 2006-03-24 | 2007-09-27 | Howell Thomas A | Medical monitoring system |
US20070233395A1 (en) * | 2006-04-03 | 2007-10-04 | Home Diagnostics, Inc. | Diagnostic meter |
US20080177149A1 (en) * | 2006-06-16 | 2008-07-24 | Stefan Weinert | System and method for collecting patient information from which diabetes therapy may be determined |
US7434724B2 (en) | 2006-12-22 | 2008-10-14 | Welch Allyn, Inc. | Dynamic barcode for displaying medical data |
US20080278332A1 (en) * | 2007-05-08 | 2008-11-13 | Abbott Diabetes Care, Inc. | Analyte monitoring system and methods |
US20080281179A1 (en) * | 2007-05-08 | 2008-11-13 | Abbott Diabetes Care, Inc. | Analyte monitoring system and methods |
US20080319296A1 (en) * | 2007-06-21 | 2008-12-25 | Abbott Diabetes Care, Inc. | Health monitor |
US20090105571A1 (en) * | 2006-06-30 | 2009-04-23 | Abbott Diabetes Care, Inc. | Method and System for Providing Data Communication in Data Management Systems |
US20090237262A1 (en) * | 2008-03-21 | 2009-09-24 | Lifescan Scotland Ltd. | Analyte testing method and system |
US20090284372A1 (en) * | 2003-06-10 | 2009-11-19 | Abbott Diabetes Care Inc. | Glucose Measuring Device For Use In Personal Area Network |
USD611151S1 (en) | 2008-06-10 | 2010-03-02 | Lifescan Scotland, Ltd. | Test meter |
USD611489S1 (en) | 2008-07-25 | 2010-03-09 | Lifescan, Inc. | User interface display for a glucose meter |
USD611372S1 (en) | 2008-09-19 | 2010-03-09 | Lifescan Scotland Limited | Analyte test meter |
USD611853S1 (en) | 2008-03-21 | 2010-03-16 | Lifescan Scotland Limited | Analyte test meter |
USD612275S1 (en) | 2008-03-21 | 2010-03-23 | Lifescan Scotland, Ltd. | Analyte test meter |
USD612274S1 (en) | 2008-01-18 | 2010-03-23 | Lifescan Scotland, Ltd. | User interface in an analyte meter |
US20100076284A1 (en) * | 2007-06-21 | 2010-03-25 | Abbott Diabetes Care Inc. | Health Management Devices and Methods |
USD615431S1 (en) | 2008-03-21 | 2010-05-11 | Lifescan Scotland Limited | Analyte test meter |
US20100274220A1 (en) * | 2005-11-04 | 2010-10-28 | Abbott Diabetes Care Inc. | Method and System for Providing Basal Profile Modification in Analyte Monitoring and Management Systems |
US20110054282A1 (en) * | 2009-08-31 | 2011-03-03 | Abbott Diabetes Care Inc. | Analyte Monitoring System and Methods for Managing Power and Noise |
US20110053844A1 (en) * | 2007-08-27 | 2011-03-03 | Walter Hinderer | Liquid formulation of g-csf conjugate |
US20110060530A1 (en) * | 2009-08-31 | 2011-03-10 | Abbott Diabetes Care Inc. | Analyte Signal Processing Device and Methods |
US8118740B2 (en) | 2004-12-20 | 2012-02-21 | Ipventure, Inc. | Moisture sensor for skin |
US8202217B2 (en) | 2004-12-20 | 2012-06-19 | Ip Venture, Inc. | Healthcare base |
US8456301B2 (en) | 2007-05-08 | 2013-06-04 | Abbott Diabetes Care Inc. | Analyte monitoring system and methods |
US8461985B2 (en) | 2007-05-08 | 2013-06-11 | Abbott Diabetes Care Inc. | Analyte monitoring system and methods |
US8593287B2 (en) | 2007-05-08 | 2013-11-26 | Abbott Diabetes Care Inc. | Analyte monitoring system and methods |
US8593109B2 (en) | 2006-03-31 | 2013-11-26 | Abbott Diabetes Care Inc. | Method and system for powering an electronic device |
US8597575B2 (en) | 2006-03-31 | 2013-12-03 | Abbott Diabetes Care Inc. | Analyte monitoring devices and methods therefor |
US8698615B2 (en) | 2007-04-14 | 2014-04-15 | Abbott Diabetes Care Inc. | Method and apparatus for providing dynamic multi-stage signal amplification in a medical device |
US8715177B2 (en) * | 2000-10-06 | 2014-05-06 | Ip Holdings, Inc. | Intelligent drug delivery appliance |
US9069536B2 (en) | 2011-10-31 | 2015-06-30 | Abbott Diabetes Care Inc. | Electronic devices having integrated reset systems and methods thereof |
US9095290B2 (en) | 2007-03-01 | 2015-08-04 | Abbott Diabetes Care Inc. | Method and apparatus for providing rolling data in communication systems |
US9226701B2 (en) | 2009-04-28 | 2016-01-05 | Abbott Diabetes Care Inc. | Error detection in critical repeating data in a wireless sensor system |
WO2016007935A3 (en) * | 2014-07-10 | 2016-04-07 | Companion Medical, Inc. | Medicine administering system including injection pen and companion device |
US9526920B2 (en) | 2010-10-12 | 2016-12-27 | Smith & Nephew, Inc. | Medical device |
US9532737B2 (en) | 2011-02-28 | 2017-01-03 | Abbott Diabetes Care Inc. | Devices, systems, and methods associated with analyte monitoring devices and devices incorporating the same |
US9574914B2 (en) | 2007-05-08 | 2017-02-21 | Abbott Diabetes Care Inc. | Method and device for determining elapsed sensor life |
US9737649B2 (en) | 2013-03-14 | 2017-08-22 | Smith & Nephew, Inc. | Systems and methods for applying reduced pressure therapy |
US9962091B2 (en) | 2002-12-31 | 2018-05-08 | Abbott Diabetes Care Inc. | Continuous glucose monitoring system and methods of use |
US9968306B2 (en) | 2012-09-17 | 2018-05-15 | Abbott Diabetes Care Inc. | Methods and apparatuses for providing adverse condition notification with enhanced wireless communication range in analyte monitoring systems |
US9980669B2 (en) | 2011-11-07 | 2018-05-29 | Abbott Diabetes Care Inc. | Analyte monitoring device and methods |
US10022499B2 (en) | 2007-02-15 | 2018-07-17 | Abbott Diabetes Care Inc. | Device and method for automatic data acquisition and/or detection |
US10136816B2 (en) | 2009-08-31 | 2018-11-27 | Abbott Diabetes Care Inc. | Medical devices and methods |
US10155070B2 (en) | 2013-08-13 | 2018-12-18 | Smith & Nephew, Inc. | Systems and methods for applying reduced pressure therapy |
US10328188B2 (en) | 2013-03-14 | 2019-06-25 | Smith & Nephew, Inc. | Systems and methods for applying reduced pressure therapy |
US10549016B2 (en) | 2014-12-30 | 2020-02-04 | Smith & Nephew, Inc. | Blockage detection in reduced pressure therapy |
US10556045B2 (en) | 2014-12-30 | 2020-02-11 | Smith & Nephew, Inc. | Synchronous pressure sampling and supply of negative pressure in negative pressure wound therapy |
USD893020S1 (en) | 2018-05-11 | 2020-08-11 | Companion Medical, Inc. | Injection pen |
USD892819S1 (en) | 2018-06-20 | 2020-08-11 | Companion Medical, Inc. | Display screen with graphical user interface |
US10744239B2 (en) | 2014-07-31 | 2020-08-18 | Smith & Nephew, Inc. | Leak detection in negative pressure wound therapy system |
US10754927B2 (en) | 2013-09-26 | 2020-08-25 | Companion Medical, Inc. | System for administering a medicament |
US10864327B2 (en) | 2016-01-29 | 2020-12-15 | Companion Medical, Inc. | Automatic medication delivery tracking |
US10898653B2 (en) | 2018-05-08 | 2021-01-26 | Companion Medical, Inc. | Intelligent medication delivery systems and methods for dose setting and dispensing monitoring |
US11006871B2 (en) | 2009-02-03 | 2021-05-18 | Abbott Diabetes Care Inc. | Analyte sensor and apparatus for insertion of the sensor |
US11294407B2 (en) | 2001-04-27 | 2022-04-05 | Roche Diabetes Care, Inc. | Device and method for insulin dosing |
US11315681B2 (en) | 2015-10-07 | 2022-04-26 | Smith & Nephew, Inc. | Reduced pressure therapy device operation and authorization monitoring |
US11383043B2 (en) | 2017-12-12 | 2022-07-12 | Bigfoot Biomedical, Inc. | Medicine injection and disease management systems, devices, and methods |
US11464459B2 (en) | 2017-12-12 | 2022-10-11 | Bigfoot Biomedical, Inc. | User interface for diabetes management systems including flash glucose monitor |
US11484657B2 (en) | 2017-06-09 | 2022-11-01 | Medtronic Minimed, Inc. | Intelligent medication delivery systems and methods |
US11568975B2 (en) | 2017-10-12 | 2023-01-31 | Medtronic Minimed, Inc. | Intelligent medication delivery systems and methods for dose recommendation and management |
US11587663B2 (en) | 2018-06-20 | 2023-02-21 | Medtronic Minimed, Inc. | Intelligent medication delivery systems and methods for medicine dose calculation and reporting |
US11602461B2 (en) | 2016-05-13 | 2023-03-14 | Smith & Nephew, Inc. | Automatic wound coupling detection in negative pressure wound therapy systems |
US11664107B2 (en) | 2018-05-08 | 2023-05-30 | Medtronic Minimed, Inc. | Intelligent medication delivery systems and methods using a prescription-regulated software application |
US11701473B2 (en) | 2021-06-23 | 2023-07-18 | Medtronic Minimed, Inc. | Reusable injection pens |
US11793936B2 (en) | 2009-05-29 | 2023-10-24 | Abbott Diabetes Care Inc. | Medical device antenna systems having external antenna configurations |
US11844923B2 (en) | 2017-12-12 | 2023-12-19 | Bigfoot Biomedical, Inc. | Devices, systems, and methods for estimating active medication from injections |
US11896797B2 (en) | 2017-12-12 | 2024-02-13 | Bigfoot Biomedical, Inc. | Pen cap for insulin injection pens and associated methods and systems |
US11931549B2 (en) | 2017-12-12 | 2024-03-19 | Bigfoot Biomedical, Inc. | User interface for diabetes management systems and devices |
US11948671B2 (en) | 2019-04-11 | 2024-04-02 | Medtronic Minimed, Inc. | Intelligent accessories for medicine dispensing device |
US11957884B2 (en) | 2017-12-12 | 2024-04-16 | Bigfoot Biomedical, Inc. | Insulin injection assistance systems, methods, and devices |
Families Citing this family (349)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US6036924A (en) | 1997-12-04 | 2000-03-14 | Hewlett-Packard Company | Cassette of lancet cartridges for sampling blood |
US6391005B1 (en) | 1998-03-30 | 2002-05-21 | Agilent Technologies, Inc. | Apparatus and method for penetration with shaft having a sensor for sensing penetration depth |
US6558320B1 (en) * | 2000-01-20 | 2003-05-06 | Medtronic Minimed, Inc. | Handheld personal data assistant (PDA) with a medical device and method of using the same |
US6554798B1 (en) | 1998-08-18 | 2003-04-29 | Medtronic Minimed, Inc. | External infusion device with remote programming, bolus estimator and/or vibration alarm capabilities |
DE69939344D1 (en) * | 1998-11-30 | 2008-09-25 | Novo Nordisk As | Method of supporting a medical self-treatment |
US6540672B1 (en) * | 1998-12-09 | 2003-04-01 | Novo Nordisk A/S | Medical system and a method of controlling the system for use by a patient for medical self treatment |
US9006175B2 (en) | 1999-06-29 | 2015-04-14 | Mannkind Corporation | Potentiation of glucose elimination |
AU2001223397A1 (en) * | 2000-02-01 | 2001-08-14 | Disetronic Licensing Ag | Configurable device and method for releasing a substance |
EP1267708A4 (en) * | 2000-03-29 | 2006-04-12 | Univ Virginia | Method, system, and computer program product for the evaluation of glycemic control in diabetes from self-monitoring data |
US9741001B2 (en) | 2000-05-18 | 2017-08-22 | Carefusion 303, Inc. | Predictive medication safety |
US10353856B2 (en) | 2011-03-17 | 2019-07-16 | Carefusion 303, Inc. | Scalable communication system |
US11087873B2 (en) | 2000-05-18 | 2021-08-10 | Carefusion 303, Inc. | Context-aware healthcare notification system |
US7860583B2 (en) | 2004-08-25 | 2010-12-28 | Carefusion 303, Inc. | System and method for dynamically adjusting patient therapy |
US9069887B2 (en) | 2000-05-18 | 2015-06-30 | Carefusion 303, Inc. | Patient-specific medication management system |
NZ522631A (en) | 2000-05-18 | 2004-07-30 | Alaris Medical Inc | Distributed remote asset and medication management drug delivery system |
US9427520B2 (en) * | 2005-02-11 | 2016-08-30 | Carefusion 303, Inc. | Management of pending medication orders |
US10062457B2 (en) | 2012-07-26 | 2018-08-28 | Carefusion 303, Inc. | Predictive notifications for adverse patient events |
WO2001093179A2 (en) * | 2000-05-26 | 2001-12-06 | Bayer Corporation | Medical management system |
US8641644B2 (en) | 2000-11-21 | 2014-02-04 | Sanofi-Aventis Deutschland Gmbh | Blood testing apparatus having a rotatable cartridge with multiple lancing elements and testing means |
US20020143434A1 (en) * | 2001-03-29 | 2002-10-03 | John Greeven | Method and apparatus for delivering and refilling pharmaceuticals |
DE60238814D1 (en) * | 2001-03-29 | 2011-02-17 | Lifescan Scotland Ltd | INTEGRATED BLOOD PROBE WITH TESTS |
GB0108213D0 (en) * | 2001-04-02 | 2001-05-23 | Glaxo Group Ltd | Medicament dispenser |
GB0108215D0 (en) * | 2001-04-02 | 2001-05-23 | Glaxo Group Ltd | Medicament dispenser |
GB0108208D0 (en) * | 2001-04-02 | 2001-05-23 | Glaxo Group Ltd | Medicament dispenser |
US7041468B2 (en) | 2001-04-02 | 2006-05-09 | Therasense, Inc. | Blood glucose tracking apparatus and methods |
US9226699B2 (en) | 2002-04-19 | 2016-01-05 | Sanofi-Aventis Deutschland Gmbh | Body fluid sampling module with a continuous compression tissue interface surface |
US9795747B2 (en) | 2010-06-02 | 2017-10-24 | Sanofi-Aventis Deutschland Gmbh | Methods and apparatus for lancet actuation |
US7033371B2 (en) | 2001-06-12 | 2006-04-25 | Pelikan Technologies, Inc. | Electric lancet actuator |
US9427532B2 (en) | 2001-06-12 | 2016-08-30 | Sanofi-Aventis Deutschland Gmbh | Tissue penetration device |
WO2002100254A2 (en) | 2001-06-12 | 2002-12-19 | Pelikan Technologies, Inc. | Method and apparatus for lancet launching device integrated onto a blood-sampling cartridge |
US8337419B2 (en) | 2002-04-19 | 2012-12-25 | Sanofi-Aventis Deutschland Gmbh | Tissue penetration device |
AU2002312521A1 (en) | 2001-06-12 | 2002-12-23 | Pelikan Technologies, Inc. | Blood sampling apparatus and method |
WO2002100461A2 (en) | 2001-06-12 | 2002-12-19 | Pelikan Technologies, Inc. | Method and apparatus for improving success rate of blood yield from a fingerstick |
EP1404233B1 (en) | 2001-06-12 | 2009-12-02 | Pelikan Technologies Inc. | Self optimizing lancing device with adaptation means to temporal variations in cutaneous properties |
US7981056B2 (en) | 2002-04-19 | 2011-07-19 | Pelikan Technologies, Inc. | Methods and apparatus for lancet actuation |
US7344507B2 (en) | 2002-04-19 | 2008-03-18 | Pelikan Technologies, Inc. | Method and apparatus for lancet actuation |
US7025774B2 (en) | 2001-06-12 | 2006-04-11 | Pelikan Technologies, Inc. | Tissue penetration device |
US7044911B2 (en) | 2001-06-29 | 2006-05-16 | Philometron, Inc. | Gateway platform for biological monitoring and delivery of therapeutic compounds |
US20080177154A1 (en) * | 2001-08-13 | 2008-07-24 | Novo Nordisk A/S | Portable Device and Method Of Communicating Medical Data Information |
JP2004538078A (en) * | 2001-08-20 | 2004-12-24 | インバネス・メディカル・リミテッド | Wireless diabetes management device and method of using wireless diabetes management device |
AU2003220125B2 (en) | 2002-03-20 | 2006-06-15 | Mannkind Corporation | Inhalation apparatus |
US8267870B2 (en) | 2002-04-19 | 2012-09-18 | Sanofi-Aventis Deutschland Gmbh | Method and apparatus for body fluid sampling with hybrid actuation |
US9795334B2 (en) | 2002-04-19 | 2017-10-24 | Sanofi-Aventis Deutschland Gmbh | Method and apparatus for penetrating tissue |
US7229458B2 (en) | 2002-04-19 | 2007-06-12 | Pelikan Technologies, Inc. | Method and apparatus for penetrating tissue |
US7232451B2 (en) | 2002-04-19 | 2007-06-19 | Pelikan Technologies, Inc. | Method and apparatus for penetrating tissue |
US7331931B2 (en) | 2002-04-19 | 2008-02-19 | Pelikan Technologies, Inc. | Method and apparatus for penetrating tissue |
US8360992B2 (en) | 2002-04-19 | 2013-01-29 | Sanofi-Aventis Deutschland Gmbh | Method and apparatus for penetrating tissue |
US7291117B2 (en) | 2002-04-19 | 2007-11-06 | Pelikan Technologies, Inc. | Method and apparatus for penetrating tissue |
US8221334B2 (en) | 2002-04-19 | 2012-07-17 | Sanofi-Aventis Deutschland Gmbh | Method and apparatus for penetrating tissue |
US7491178B2 (en) | 2002-04-19 | 2009-02-17 | Pelikan Technologies, Inc. | Method and apparatus for penetrating tissue |
US7297122B2 (en) | 2002-04-19 | 2007-11-20 | Pelikan Technologies, Inc. | Method and apparatus for penetrating tissue |
US9314194B2 (en) | 2002-04-19 | 2016-04-19 | Sanofi-Aventis Deutschland Gmbh | Tissue penetration device |
US7892185B2 (en) | 2002-04-19 | 2011-02-22 | Pelikan Technologies, Inc. | Method and apparatus for body fluid sampling and analyte sensing |
US7717863B2 (en) | 2002-04-19 | 2010-05-18 | Pelikan Technologies, Inc. | Method and apparatus for penetrating tissue |
US8579831B2 (en) | 2002-04-19 | 2013-11-12 | Sanofi-Aventis Deutschland Gmbh | Method and apparatus for penetrating tissue |
US7892183B2 (en) | 2002-04-19 | 2011-02-22 | Pelikan Technologies, Inc. | Method and apparatus for body fluid sampling and analyte sensing |
US7909778B2 (en) | 2002-04-19 | 2011-03-22 | Pelikan Technologies, Inc. | Method and apparatus for penetrating tissue |
US7674232B2 (en) | 2002-04-19 | 2010-03-09 | Pelikan Technologies, Inc. | Method and apparatus for penetrating tissue |
US7713214B2 (en) | 2002-04-19 | 2010-05-11 | Pelikan Technologies, Inc. | Method and apparatus for a multi-use body fluid sampling device with optical analyte sensing |
US7371247B2 (en) | 2002-04-19 | 2008-05-13 | Pelikan Technologies, Inc | Method and apparatus for penetrating tissue |
US7976476B2 (en) | 2002-04-19 | 2011-07-12 | Pelikan Technologies, Inc. | Device and method for variable speed lancet |
US8784335B2 (en) | 2002-04-19 | 2014-07-22 | Sanofi-Aventis Deutschland Gmbh | Body fluid sampling device with a capacitive sensor |
US7648468B2 (en) | 2002-04-19 | 2010-01-19 | Pelikon Technologies, Inc. | Method and apparatus for penetrating tissue |
US8702624B2 (en) | 2006-09-29 | 2014-04-22 | Sanofi-Aventis Deutschland Gmbh | Analyte measurement device with a single shot actuator |
US9248267B2 (en) | 2002-04-19 | 2016-02-02 | Sanofi-Aventis Deustchland Gmbh | Tissue penetration device |
US7547287B2 (en) | 2002-04-19 | 2009-06-16 | Pelikan Technologies, Inc. | Method and apparatus for penetrating tissue |
US7901362B2 (en) | 2002-04-19 | 2011-03-08 | Pelikan Technologies, Inc. | Method and apparatus for penetrating tissue |
DE10219098A1 (en) * | 2002-04-29 | 2003-11-13 | Siemens Ag | Patient medical data access management system comprises a centralized or decentralized data record, e.g. a CD-RW disk, with biometric or password controlled access and an expert system for preventing examination duplication |
US7048141B2 (en) * | 2002-05-14 | 2006-05-23 | Antioch Holdings, Inc. | Personal medication dispenser |
US20060213921A1 (en) * | 2005-03-23 | 2006-09-28 | Gazi Abdulhay | Pill dispensing apparatus |
US20050160858A1 (en) * | 2002-07-24 | 2005-07-28 | M 2 Medical A/S | Shape memory alloy actuator |
EP1545656A1 (en) * | 2002-07-24 | 2005-06-29 | M 2 Medical A/S | An infusion pump system, an infusion pump unit and an infusion pump |
EP1560616B1 (en) | 2002-11-05 | 2018-01-24 | Bigfoot Biomedical, Inc. | A disposable wearable insulin dispensing device, a combination of such a device and a programming controller |
AU2003287926A1 (en) | 2002-12-23 | 2004-07-14 | M2 Medical A/S | A disposable, wearable insulin dispensing device, a combination of such a device and a programming controller and a method of controlling the operation of such a device |
CN1732027A (en) * | 2002-12-23 | 2006-02-08 | M2医药有限公司 | Flexible piston rod |
US8574895B2 (en) | 2002-12-30 | 2013-11-05 | Sanofi-Aventis Deutschland Gmbh | Method and apparatus using optical techniques to measure analyte levels |
DE602004028463D1 (en) | 2003-05-30 | 2010-09-16 | Pelikan Technologies Inc | METHOD AND DEVICE FOR INJECTING LIQUID |
US7850621B2 (en) | 2003-06-06 | 2010-12-14 | Pelikan Technologies, Inc. | Method and apparatus for body fluid sampling and analyte sensing |
US8460243B2 (en) | 2003-06-10 | 2013-06-11 | Abbott Diabetes Care Inc. | Glucose measuring module and insulin pump combination |
WO2006001797A1 (en) | 2004-06-14 | 2006-01-05 | Pelikan Technologies, Inc. | Low pain penetrating |
EP1635702A4 (en) * | 2003-06-11 | 2009-01-21 | Pelikan Technologies Inc | Method and apparatus for body fluid sampling and analyte sensing |
US20050055243A1 (en) * | 2003-06-30 | 2005-03-10 | Dave Arndt | Method and apparatus for managing data received from a medical device |
US7722536B2 (en) * | 2003-07-15 | 2010-05-25 | Abbott Diabetes Care Inc. | Glucose measuring device integrated into a holster for a personal area network device |
US8282576B2 (en) | 2003-09-29 | 2012-10-09 | Sanofi-Aventis Deutschland Gmbh | Method and apparatus for an improved sample capture device |
US9123077B2 (en) | 2003-10-07 | 2015-09-01 | Hospira, Inc. | Medication management system |
US8065161B2 (en) | 2003-11-13 | 2011-11-22 | Hospira, Inc. | System for maintaining drug information and communicating with medication delivery devices |
EP1680014A4 (en) | 2003-10-14 | 2009-01-21 | Pelikan Technologies Inc | Method and apparatus for a variable user interface |
WO2005041103A2 (en) * | 2003-10-29 | 2005-05-06 | Novo Nordisk A/S | Medical advisory system |
US20050108053A1 (en) * | 2003-11-14 | 2005-05-19 | Jones Miles J.Jr. | Interactive internet medical pharmaceutical prescribing system |
EP1706026B1 (en) | 2003-12-31 | 2017-03-01 | Sanofi-Aventis Deutschland GmbH | Method and apparatus for improving fluidic flow and sample capture |
US7822454B1 (en) | 2005-01-03 | 2010-10-26 | Pelikan Technologies, Inc. | Fluid sampling device with improved analyte detecting member configuration |
US7753879B2 (en) * | 2004-01-29 | 2010-07-13 | M2 Group Holdings, Inc. | Disposable medicine dispensing device |
JP2007524312A (en) * | 2004-02-26 | 2007-08-23 | ノボ・ノルデイスク・エー/エス | Method and system for secure pairing of wireless communication devices |
JP2007529928A (en) * | 2004-03-19 | 2007-10-25 | ノボ・ノルデイスク・エー/エス | Reducing the format size of packet headers used for data transmission of medical devices |
JP2007535974A (en) * | 2004-03-26 | 2007-12-13 | ノボ・ノルデイスク・エー/エス | Display device for related data of diabetic patients |
ES2772853T3 (en) * | 2004-04-30 | 2020-07-08 | Becton Dickinson Co | Systems and procedures for administering a medical regimen |
EP1751546A2 (en) | 2004-05-20 | 2007-02-14 | Albatros Technologies GmbH & Co. KG | Printable hydrogel for biosensors |
US9775553B2 (en) | 2004-06-03 | 2017-10-03 | Sanofi-Aventis Deutschland Gmbh | Method and apparatus for a fluid sampling device |
EP1765194A4 (en) | 2004-06-03 | 2010-09-29 | Pelikan Technologies Inc | Method and apparatus for a fluid sampling device |
WO2005119524A2 (en) | 2004-06-04 | 2005-12-15 | Therasense, Inc. | Diabetes care host-client architecture and data management system |
US7344500B2 (en) * | 2004-07-27 | 2008-03-18 | Medtronic Minimed, Inc. | Sensing system with auxiliary display |
PL1786784T3 (en) | 2004-08-20 | 2011-04-29 | Mannkind Corp | Catalysis of diketopiperazine synthesis |
EP2322180B1 (en) | 2004-08-23 | 2015-05-27 | MannKind Corporation | Diketopiperazine salts for drug delivery |
US7608042B2 (en) * | 2004-09-29 | 2009-10-27 | Intellidx, Inc. | Blood monitoring system |
US20060229531A1 (en) * | 2005-02-01 | 2006-10-12 | Daniel Goldberger | Blood monitoring system |
US20070191716A1 (en) * | 2004-09-29 | 2007-08-16 | Daniel Goldberger | Blood monitoring system |
EP1815375A2 (en) * | 2004-11-15 | 2007-08-08 | Novo Nordisk A/S | Method and apparatus for monitoring long term and short term effects of a treatment |
DE102004057503B4 (en) | 2004-11-29 | 2013-11-21 | Roche Diagnostics Gmbh | Diagnostic system for determining substance concentrations in liquid samples |
EP1669020A1 (en) * | 2004-12-07 | 2006-06-14 | Roche Diagnostics GmbH | Storage case with integrated functions |
US8652831B2 (en) | 2004-12-30 | 2014-02-18 | Sanofi-Aventis Deutschland Gmbh | Method and apparatus for analyte measurement test time |
ITBO20050002A1 (en) * | 2005-01-04 | 2006-07-05 | Giacomo Vespasiani | METHOD AND SYSTEM FOR INTERACTIVE MANAGEMENT OF DATA CONCERNING AN INSULIN THERAPY IN SELF-CONTROL FOR A DIABETIC PATIENT |
US8202245B2 (en) * | 2005-01-26 | 2012-06-19 | Boston Scientific Scimed, Inc. | Medical devices and methods of making the same |
US8361026B2 (en) | 2005-02-01 | 2013-01-29 | Intelliject, Inc. | Apparatus and methods for self-administration of vaccines and other medicaments |
US9022980B2 (en) | 2005-02-01 | 2015-05-05 | Kaleo, Inc. | Medical injector simulation device |
US8226610B2 (en) | 2005-02-01 | 2012-07-24 | Intelliject, Inc. | Medical injector with compliance tracking and monitoring |
US8231573B2 (en) * | 2005-02-01 | 2012-07-31 | Intelliject, Inc. | Medicament delivery device having an electronic circuit system |
US7731686B2 (en) * | 2005-02-01 | 2010-06-08 | Intelliject, Inc. | Devices, systems and methods for medicament delivery |
US8206360B2 (en) | 2005-02-01 | 2012-06-26 | Intelliject, Inc. | Devices, systems and methods for medicament delivery |
JP4948422B2 (en) | 2005-02-01 | 2012-06-06 | インテリジェクト,インコーポレイテッド | Drug delivery apparatus, system and method |
US7785258B2 (en) * | 2005-10-06 | 2010-08-31 | Optiscan Biomedical Corporation | System and method for determining a treatment dose for a patient |
US8251907B2 (en) * | 2005-02-14 | 2012-08-28 | Optiscan Biomedical Corporation | System and method for determining a treatment dose for a patient |
EP1877115A1 (en) * | 2005-04-06 | 2008-01-16 | M 2 Medical A/S | An actuator |
US20090227855A1 (en) * | 2005-08-16 | 2009-09-10 | Medtronic Minimed, Inc. | Controller device for an infusion pump |
RU2390325C2 (en) | 2005-09-14 | 2010-05-27 | Маннкайнд Корпорейшн | Method for preparing drug based on higher affinity of active agents to crystalline microparticle surfaces |
US8409142B2 (en) | 2005-09-26 | 2013-04-02 | Asante Solutions, Inc. | Operating an infusion pump system |
US7794427B2 (en) * | 2005-09-26 | 2010-09-14 | Asante Solutions, Inc. | Operating an infusion pump system |
US8551046B2 (en) | 2006-09-18 | 2013-10-08 | Asante Solutions, Inc. | Dispensing fluid from an infusion pump system |
US8057436B2 (en) | 2005-09-26 | 2011-11-15 | Asante Solutions, Inc. | Dispensing fluid from an infusion pump system |
US7534226B2 (en) * | 2005-09-26 | 2009-05-19 | M2 Group Holdings, Inc. | Dispensing fluid from an infusion pump system |
US8105279B2 (en) | 2005-09-26 | 2012-01-31 | M2 Group Holdings, Inc. | Dispensing fluid from an infusion pump system |
US8764654B2 (en) | 2008-03-19 | 2014-07-01 | Zin Technologies, Inc. | Data acquisition for modular biometric monitoring system |
US8951190B2 (en) * | 2005-09-28 | 2015-02-10 | Zin Technologies, Inc. | Transfer function control for biometric monitoring system |
US20070073266A1 (en) * | 2005-09-28 | 2007-03-29 | Zin Technologies | Compact wireless biometric monitoring and real time processing system |
ATE439155T1 (en) * | 2005-11-08 | 2009-08-15 | M2 Medical As | INFUSION PUMP SYSTEM |
EP1955240B8 (en) | 2005-11-08 | 2016-03-30 | Bigfoot Biomedical, Inc. | Method for manual and autonomous control of an infusion pump |
DE102006051562A1 (en) * | 2005-11-15 | 2007-05-16 | Weinmann G Geraete Med | Signal emitter for forming signals from measured physiological variable values, especially to control therapeutic devices, by detecting electromagnetic waves passed through or reflected from sample |
US20080200838A1 (en) * | 2005-11-28 | 2008-08-21 | Daniel Goldberger | Wearable, programmable automated blood testing system |
US20070123801A1 (en) * | 2005-11-28 | 2007-05-31 | Daniel Goldberger | Wearable, programmable automated blood testing system |
JP5292104B2 (en) * | 2006-01-05 | 2013-09-18 | ユニバーシティ オブ バージニア パテント ファウンデーション | Computer-implemented method, system, and computer program for evaluating blood glucose variability in diabetes from self-monitoring data |
RU2403059C2 (en) | 2006-02-22 | 2010-11-10 | Маннкайнд Корпорейшн | Method of improving pharmaceutical properties of particles, containing diketopiperazine and active agent |
CA2646279C (en) | 2006-03-23 | 2015-12-08 | Becton, Dickinson And Company | System and methods for improved diabetes data management and use employing wireless connectivity between patients and healthcare providers and repository of diabetes management information |
ES2297779T3 (en) * | 2006-03-30 | 2008-05-01 | F. Hoffmann-La Roche Ag | INFUSION SYSTEM WITH AN INFUSION UNIT AND A DISTANCE CONTROL UNIT. |
US20070260480A1 (en) * | 2006-05-04 | 2007-11-08 | Johan Cederlund | Managing health related variables in a remote data collection system |
US8092385B2 (en) * | 2006-05-23 | 2012-01-10 | Intellidx, Inc. | Fluid access interface |
US20070276197A1 (en) * | 2006-05-24 | 2007-11-29 | Lifescan, Inc. | Systems and methods for providing individualized disease management |
JP2010507176A (en) | 2006-10-16 | 2010-03-04 | ホスピラ・インコーポレイテツド | System and method for comparing and utilizing dynamic information and configuration information from multiple device management systems |
US20080139910A1 (en) * | 2006-12-06 | 2008-06-12 | Metronic Minimed, Inc. | Analyte sensor and method of using the same |
US20080154513A1 (en) * | 2006-12-21 | 2008-06-26 | University Of Virginia Patent Foundation | Systems, Methods and Computer Program Codes for Recognition of Patterns of Hyperglycemia and Hypoglycemia, Increased Glucose Variability, and Ineffective Self-Monitoring in Diabetes |
WO2008111938A1 (en) * | 2007-03-12 | 2008-09-18 | Bayer Healthcare Llc | Test-sensor cartridge |
EP2122345A1 (en) | 2007-03-12 | 2009-11-25 | Bayer Healthcare, LLC | Analyte-testing instruments |
US8758245B2 (en) * | 2007-03-20 | 2014-06-24 | Lifescan, Inc. | Systems and methods for pattern recognition in diabetes management |
US20080234943A1 (en) * | 2007-03-20 | 2008-09-25 | Pinaki Ray | Computer program for diabetes management |
US20080235053A1 (en) * | 2007-03-20 | 2008-09-25 | Pinaki Ray | Communication medium for diabetes management |
WO2008137405A1 (en) * | 2007-05-01 | 2008-11-13 | F. Hoffmann-La Roche Ag | Management of inhalable insulin data |
US7972296B2 (en) | 2007-10-10 | 2011-07-05 | Optiscan Biomedical Corporation | Fluid component analysis system and method for glucose monitoring and control |
US8417311B2 (en) | 2008-09-12 | 2013-04-09 | Optiscan Biomedical Corporation | Fluid component analysis system and method for glucose monitoring and control |
US7794426B2 (en) | 2007-05-21 | 2010-09-14 | Asante Solutions, Inc. | Infusion pump system with contamination-resistant features |
US7981102B2 (en) * | 2007-05-21 | 2011-07-19 | Asante Solutions, Inc. | Removable controller for an infusion pump |
US7833196B2 (en) * | 2007-05-21 | 2010-11-16 | Asante Solutions, Inc. | Illumination instrument for an infusion pump |
US7892199B2 (en) * | 2007-05-21 | 2011-02-22 | Asante Solutions, Inc. | Occlusion sensing for an infusion pump |
US7717903B2 (en) * | 2007-09-06 | 2010-05-18 | M2 Group Holdings, Inc. | Operating an infusion pump system |
US7828528B2 (en) * | 2007-09-06 | 2010-11-09 | Asante Solutions, Inc. | Occlusion sensing system for infusion pumps |
US8032226B2 (en) | 2007-09-07 | 2011-10-04 | Asante Solutions, Inc. | User profile backup system for an infusion pump device |
US7935076B2 (en) | 2007-09-07 | 2011-05-03 | Asante Solutions, Inc. | Activity sensing techniques for an infusion pump system |
US8287514B2 (en) | 2007-09-07 | 2012-10-16 | Asante Solutions, Inc. | Power management techniques for an infusion pump system |
US7879026B2 (en) * | 2007-09-07 | 2011-02-01 | Asante Solutions, Inc. | Controlled adjustment of medicine dispensation from an infusion pump device |
US9026370B2 (en) | 2007-12-18 | 2015-05-05 | Hospira, Inc. | User interface improvements for medical devices |
DK2073135T3 (en) * | 2007-12-21 | 2019-01-02 | Hoffmann La Roche | Blood glucose system with time synchronization |
US9550031B2 (en) * | 2008-02-01 | 2017-01-24 | Reciprocal Labs Corporation | Device and method to monitor, track, map, and analyze usage of metered-dose inhalers in real-time |
US8234126B1 (en) | 2008-02-12 | 2012-07-31 | Asante Solutions, Inc. | Distribution of infusion pumps |
US20090240127A1 (en) * | 2008-03-20 | 2009-09-24 | Lifescan, Inc. | Methods of determining pre or post meal time slots or intervals in diabetes management |
US9220456B2 (en) | 2008-04-04 | 2015-12-29 | Hygieia, Inc. | Systems, methods and devices for achieving glycemic balance |
US10624577B2 (en) | 2008-04-04 | 2020-04-21 | Hygieia, Inc. | Systems, devices, and methods for alleviating glucotoxicity and restoring pancreatic beta-cell function in advanced diabetes mellitus |
WO2009146119A2 (en) * | 2008-04-04 | 2009-12-03 | Hygieia, Inc. | System for optimizing a patient's insulin dosage regimen |
WO2009126900A1 (en) | 2008-04-11 | 2009-10-15 | Pelikan Technologies, Inc. | Method and apparatus for analyte detecting device |
WO2009131664A2 (en) * | 2008-04-21 | 2009-10-29 | Carl Frederick Edman | Metabolic energy monitoring system |
US20100256047A1 (en) * | 2009-04-03 | 2010-10-07 | Lifescan, Inc. | Analyte Measurement and Management Device and Associated Methods |
USD994111S1 (en) | 2008-05-12 | 2023-08-01 | Kaleo, Inc. | Medicament delivery device cover |
CA3142745A1 (en) | 2008-05-20 | 2009-11-26 | Avant Medical Corp. | Autoinjector system |
US8052645B2 (en) | 2008-07-23 | 2011-11-08 | Avant Medical Corp. | System and method for an injection using a syringe needle |
US8177749B2 (en) | 2008-05-20 | 2012-05-15 | Avant Medical Corp. | Cassette for a hidden injection needle |
US8117481B2 (en) * | 2008-06-06 | 2012-02-14 | Roche Diagnostics International Ag | Apparatus and method for processing wirelessly communicated information within an electronic device |
US8132037B2 (en) | 2008-06-06 | 2012-03-06 | Roche Diagnostics International Ag | Apparatus and method for processing wirelessly communicated data and clock information within an electronic device |
US8485180B2 (en) | 2008-06-13 | 2013-07-16 | Mannkind Corporation | Dry powder drug delivery system |
US8636001B2 (en) | 2008-06-13 | 2014-01-28 | Mannkind Corporation | Dry powder inhaler and system for drug delivery |
DK2609954T3 (en) | 2008-06-20 | 2022-02-14 | Mannkind Corp | Interactive device for real-time imaging of inhalation performance |
TWI614024B (en) | 2008-08-11 | 2018-02-11 | 曼凱公司 | Use of ultrarapid acting insulin |
US7959598B2 (en) | 2008-08-20 | 2011-06-14 | Asante Solutions, Inc. | Infusion pump systems and methods |
WO2010056718A2 (en) | 2008-11-11 | 2010-05-20 | Hygieia, Inc. | Apparatus and system for diabetes management |
US8314106B2 (en) | 2008-12-29 | 2012-11-20 | Mannkind Corporation | Substituted diketopiperazine analogs for use as drug delivery agents |
US9375169B2 (en) | 2009-01-30 | 2016-06-28 | Sanofi-Aventis Deutschland Gmbh | Cam drive for managing disposable penetrating member actions with a single motor and motor and control system |
ES2709106T3 (en) | 2009-02-27 | 2019-04-15 | Lifescan Inc | Systems and methods of management of drug administration |
EP2405963B1 (en) | 2009-03-11 | 2013-11-06 | MannKind Corporation | Apparatus, system and method for measuring resistance of an inhaler |
US8753290B2 (en) * | 2009-03-27 | 2014-06-17 | Intellectual Inspiration, Llc | Fluid transfer system and method |
US8271106B2 (en) | 2009-04-17 | 2012-09-18 | Hospira, Inc. | System and method for configuring a rule set for medical event management and responses |
CN102647979B (en) | 2009-06-12 | 2015-03-04 | 曼金德公司 | Diketopiperazine particles with defined specific surface areas |
JP2012532323A (en) * | 2009-06-30 | 2012-12-13 | ライフスキャン・インコーポレイテッド | Analyte testing method and system |
EP2496295A1 (en) | 2009-11-03 | 2012-09-12 | MannKind Corporation | An apparatus and method for simulating inhalation efforts |
US8771251B2 (en) * | 2009-12-17 | 2014-07-08 | Hospira, Inc. | Systems and methods for managing and delivering patient therapy through electronic drug delivery systems |
US11660392B2 (en) | 2010-02-05 | 2023-05-30 | Deka Products Limited Partnership | Devices, methods and systems for wireless control of medical devices |
CA2789141C (en) * | 2010-02-05 | 2018-06-12 | Deka Products Limited Partnership | Infusion pump apparatus, method and system |
WO2011112972A2 (en) * | 2010-03-11 | 2011-09-15 | Philometron, Inc. | Physiological monitor system for determining medication delivery and outcome |
TWI633902B (en) * | 2010-03-22 | 2018-09-01 | 賽諾菲阿凡提斯德意志有限公司 | Device, method, system and computer program for determining information related to a medical device |
US8965476B2 (en) | 2010-04-16 | 2015-02-24 | Sanofi-Aventis Deutschland Gmbh | Tissue penetration device |
USD669165S1 (en) | 2010-05-27 | 2012-10-16 | Asante Solutions, Inc. | Infusion pump |
EP2582421A1 (en) | 2010-06-21 | 2013-04-24 | MannKind Corporation | Dry powder drug delivery system and methods |
US11901069B2 (en) | 2010-08-12 | 2024-02-13 | Fenwal, Inc. | Processing blood donation data for presentation on operator interface |
US8676600B2 (en) | 2010-08-12 | 2014-03-18 | Fenwal, Inc | Mobile applications for blood centers |
US10201296B2 (en) | 2010-11-11 | 2019-02-12 | Ascensia Diabetes Care Holdings Ag | Apparatus, systems, and methods adapted to transmit analyte data having common electronic architecture |
US8627816B2 (en) | 2011-02-28 | 2014-01-14 | Intelliject, Inc. | Medicament delivery device for administration of opioid antagonists including formulations for naloxone |
US9084849B2 (en) | 2011-01-26 | 2015-07-21 | Kaleo, Inc. | Medicament delivery devices for administration of a medicament within a prefilled syringe |
US8939943B2 (en) | 2011-01-26 | 2015-01-27 | Kaleo, Inc. | Medicament delivery device for administration of opioid antagonists including formulations for naloxone |
US8852152B2 (en) | 2011-02-09 | 2014-10-07 | Asante Solutions, Inc. | Infusion pump systems and methods |
US10136845B2 (en) | 2011-02-28 | 2018-11-27 | Abbott Diabetes Care Inc. | Devices, systems, and methods associated with analyte monitoring devices and devices incorporating the same |
US8454581B2 (en) | 2011-03-16 | 2013-06-04 | Asante Solutions, Inc. | Infusion pump systems and methods |
WO2012135765A2 (en) | 2011-04-01 | 2012-10-04 | Mannkind Corporation | Blister package for pharmaceutical cartridges |
JP6038884B2 (en) | 2011-04-20 | 2016-12-07 | アムゲン・インコーポレーテッド | Automatic injection device |
WO2012174472A1 (en) | 2011-06-17 | 2012-12-20 | Mannkind Corporation | High capacity diketopiperazine microparticles |
US8585657B2 (en) | 2011-06-21 | 2013-11-19 | Asante Solutions, Inc. | Dispensing fluid from an infusion pump system |
AU2012299169B2 (en) | 2011-08-19 | 2017-08-24 | Icu Medical, Inc. | Systems and methods for a graphical interface including a graphical representation of medical data |
US8808230B2 (en) | 2011-09-07 | 2014-08-19 | Asante Solutions, Inc. | Occlusion detection for an infusion pump system |
WO2013059615A1 (en) | 2011-10-21 | 2013-04-25 | Hospira, Inc. | Medical device update system |
CN103945859A (en) | 2011-10-24 | 2014-07-23 | 曼金德公司 | Methods and compositions for treating pain |
WO2013090709A1 (en) | 2011-12-16 | 2013-06-20 | Hospira, Inc. | System for monitoring and delivering medication to a patient and method of using the same to minimize the risks associated with automated therapy |
ES2741725T3 (en) | 2012-03-30 | 2020-02-12 | Icu Medical Inc | Air detection system and method to detect air in a pump of an infusion system |
USD898908S1 (en) | 2012-04-20 | 2020-10-13 | Amgen Inc. | Pharmaceutical product cassette for an injection device |
US9522235B2 (en) | 2012-05-22 | 2016-12-20 | Kaleo, Inc. | Devices and methods for delivering medicaments from a multi-chamber container |
US20130338464A1 (en) * | 2012-06-19 | 2013-12-19 | DENNIS Ryan STAINKEN | Self-contained blood glucose testing apparatus |
EP3767632A1 (en) | 2012-06-25 | 2021-01-20 | Gecko Health Innovations, Inc. | Devices, systems, and methods for adherence monitoring and patient interaction |
US9802012B2 (en) | 2012-07-12 | 2017-10-31 | Mannkind Corporation | Dry powder drug delivery system and methods |
US8454557B1 (en) | 2012-07-19 | 2013-06-04 | Asante Solutions, Inc. | Infusion pump system and method |
US8454562B1 (en) | 2012-07-20 | 2013-06-04 | Asante Solutions, Inc. | Infusion pump system and method |
US10463788B2 (en) | 2012-07-31 | 2019-11-05 | Icu Medical, Inc. | Patient care system for critical medications |
GB2507104A (en) | 2012-10-19 | 2014-04-23 | Nicoventures Holdings Ltd | Electronic inhalation device |
US10159644B2 (en) | 2012-10-26 | 2018-12-25 | Mannkind Corporation | Inhalable vaccine compositions and methods |
US9427523B2 (en) | 2012-12-10 | 2016-08-30 | Bigfoot Biomedical, Inc. | Infusion pump system and method |
US9402954B1 (en) * | 2012-12-10 | 2016-08-02 | Richard S. Slevin | Medical injector |
US20140276536A1 (en) | 2013-03-14 | 2014-09-18 | Asante Solutions, Inc. | Infusion Pump System and Methods |
GB2526948A (en) | 2012-12-27 | 2015-12-09 | Kaleo Inc | Systems for locating and interacting with medicament delivery devices |
US10383580B2 (en) | 2012-12-31 | 2019-08-20 | Abbott Diabetes Care Inc. | Analysis of glucose median, variability, and hypoglycemia risk for therapy guidance |
US9351670B2 (en) | 2012-12-31 | 2016-05-31 | Abbott Diabetes Care Inc. | Glycemic risk determination based on variability of glucose levels |
JP6366607B2 (en) | 2013-01-15 | 2018-08-01 | サノフィ−アベンティス・ドイチュラント・ゲゼルシャフト・ミット・ベシュレンクテル・ハフツング | Auxiliary devices attached to medical injection devices to generate usage reports in digital image format for use of injection devices |
US11182728B2 (en) | 2013-01-30 | 2021-11-23 | Carefusion 303, Inc. | Medication workflow management |
US10430554B2 (en) | 2013-05-23 | 2019-10-01 | Carefusion 303, Inc. | Medication preparation queue |
US9446186B2 (en) | 2013-03-01 | 2016-09-20 | Bigfoot Biomedical, Inc. | Operating an infusion pump system |
EP2964079B1 (en) | 2013-03-06 | 2022-02-16 | ICU Medical, Inc. | Medical device communication method |
EP4195119A1 (en) | 2013-03-13 | 2023-06-14 | Carefusion 303 Inc. | Predictive medication safety |
BR112015019758B1 (en) | 2013-03-13 | 2022-07-05 | Carefusion 303, Inc | SYSTEM AND METHOD FOR USE WITH MEDICAL DEVICE TO REDUCE MEDICATION ERRORS AND MACHINE-READABLE STORAGE MEDIA |
SG11201507564PA (en) | 2013-03-15 | 2015-10-29 | Mannkind Corp | Microcrystalline diketopiperazine compositions and methods |
TWI580451B (en) | 2013-03-15 | 2017-05-01 | 安美基公司 | Cassette for an injector and method of using an autoinjector apparatus having an autoinjector and a cassette |
EP3409201B1 (en) | 2013-03-15 | 2024-04-10 | Abbott Diabetes Care, Inc. | System and method to manage diabetes based on glucose median, glucose variability, and hypoglycemic risk |
US10492990B2 (en) | 2013-03-15 | 2019-12-03 | Amgen Inc. | Drug cassette, autoinjector, and autoinjector system |
US9237866B2 (en) * | 2013-04-29 | 2016-01-19 | Birch Narrows Development, LLC | Blood glucose management |
WO2014190264A1 (en) | 2013-05-24 | 2014-11-27 | Hospira, Inc. | Multi-sensor infusion system for detecting air or an occlusion in the infusion system |
EP3003442B1 (en) | 2013-05-29 | 2020-12-30 | ICU Medical, Inc. | Infusion system and method of use which prevents over-saturation of an analog-to-digital converter |
CA2913915C (en) | 2013-05-29 | 2022-03-29 | Hospira, Inc. | Infusion system which utilizes one or more sensors and additional information to make an air determination regarding the infusion system |
US9446187B2 (en) | 2013-06-03 | 2016-09-20 | Bigfoot Biomedical, Inc. | Infusion pump system and method |
US9457141B2 (en) | 2013-06-03 | 2016-10-04 | Bigfoot Biomedical, Inc. | Infusion pump system and method |
MX2020009878A (en) | 2013-07-18 | 2022-07-27 | Mannkind Corp | Heat-stable dry powder pharmaceutical compositions and methods. |
US9561324B2 (en) | 2013-07-19 | 2017-02-07 | Bigfoot Biomedical, Inc. | Infusion pump system and method |
EP3030294B1 (en) | 2013-08-05 | 2020-10-07 | MannKind Corporation | Insufflation apparatus |
EP3038687B1 (en) | 2013-08-28 | 2019-02-27 | Gecko Health Innovations, Inc. | Devices for adherence monitoring and devices for monitoring use of consumable dispensers |
CA2922425C (en) | 2013-08-30 | 2023-05-16 | Hospira, Inc. | System and method of monitoring and managing a remote infusion regimen |
US9662436B2 (en) | 2013-09-20 | 2017-05-30 | Icu Medical, Inc. | Fail-safe drug infusion therapy system |
US10311972B2 (en) | 2013-11-11 | 2019-06-04 | Icu Medical, Inc. | Medical device system performance index |
EP3071253B1 (en) | 2013-11-19 | 2019-05-22 | ICU Medical, Inc. | Infusion pump automation system and method |
US10569015B2 (en) | 2013-12-02 | 2020-02-25 | Bigfoot Biomedical, Inc. | Infusion pump system and method |
CN106455980B (en) | 2014-01-10 | 2022-02-11 | 安晟信医疗科技控股公司 | Setting synchronization apparatus and method for end-user medical devices |
GB2523989B (en) | 2014-01-30 | 2020-07-29 | Insulet Netherlands B V | Therapeutic product delivery system and method of pairing |
US9898585B2 (en) | 2014-01-31 | 2018-02-20 | Aseko, Inc. | Method and system for insulin management |
US9486580B2 (en) | 2014-01-31 | 2016-11-08 | Aseko, Inc. | Insulin management |
EP3110474B1 (en) | 2014-02-28 | 2019-12-18 | ICU Medical, Inc. | Infusion system and method which utilizes dual wavelength optical air-in-line detection |
US10307464B2 (en) | 2014-03-28 | 2019-06-04 | Mannkind Corporation | Use of ultrarapid acting insulin |
TWI686177B (en) | 2014-04-11 | 2020-03-01 | 瑞士商安晟信醫療科技控股公司 | Wireless transmitter adapters for battery-operated biosensor meters and methods of providing same |
WO2015168427A1 (en) | 2014-04-30 | 2015-11-05 | Hospira, Inc. | Patient care system with conditional alarm forwarding |
JP2017517302A (en) | 2014-05-29 | 2017-06-29 | ホスピーラ インコーポレイテッド | Infusion system and pump with configurable closed loop delivery rate catchup |
US9724470B2 (en) | 2014-06-16 | 2017-08-08 | Icu Medical, Inc. | System for monitoring and delivering medication to a patient and method of using the same to minimize the risks associated with automated therapy |
US9629901B2 (en) | 2014-07-01 | 2017-04-25 | Bigfoot Biomedical, Inc. | Glucagon administration system and methods |
WO2016007188A1 (en) * | 2014-07-07 | 2016-01-14 | Bayer Healthcare Llc | Improved device pairing taking into account at least one condition |
US9517307B2 (en) | 2014-07-18 | 2016-12-13 | Kaleo, Inc. | Devices and methods for delivering opioid antagonists including formulations for naloxone |
US10137246B2 (en) | 2014-08-06 | 2018-11-27 | Bigfoot Biomedical, Inc. | Infusion pump assembly and method |
US9919096B2 (en) | 2014-08-26 | 2018-03-20 | Bigfoot Biomedical, Inc. | Infusion pump system and method |
US9539383B2 (en) | 2014-09-15 | 2017-01-10 | Hospira, Inc. | System and method that matches delayed infusion auto-programs with manually entered infusion programs and analyzes differences therein |
US10561806B2 (en) | 2014-10-02 | 2020-02-18 | Mannkind Corporation | Mouthpiece cover for an inhaler |
AU2015339576B2 (en) | 2014-10-27 | 2020-02-06 | Aseko, Inc. | Subcutaneous outpatient management |
US11081226B2 (en) | 2014-10-27 | 2021-08-03 | Aseko, Inc. | Method and controller for administering recommended insulin dosages to a patient |
US11344668B2 (en) | 2014-12-19 | 2022-05-31 | Icu Medical, Inc. | Infusion system with concurrent TPN/insulin infusion |
US10737024B2 (en) | 2015-02-18 | 2020-08-11 | Insulet Corporation | Fluid delivery and infusion devices, and methods of use thereof |
US10850024B2 (en) | 2015-03-02 | 2020-12-01 | Icu Medical, Inc. | Infusion system, device, and method having advanced infusion features |
CA2980004C (en) | 2015-03-24 | 2023-10-10 | Kaleo, Inc. | Devices and methods for delivering a lyophilized medicament |
US9878097B2 (en) | 2015-04-29 | 2018-01-30 | Bigfoot Biomedical, Inc. | Operating an infusion pump system |
CN107636707A (en) | 2015-04-29 | 2018-01-26 | 安晟信医疗科技控股公司 | Location-based wireless diabetes management system, method and apparatus |
ES2845725T3 (en) | 2015-05-26 | 2021-07-27 | Icu Medical Inc | Infusion pump system and method with multiple drug library editor source capability |
WO2017004345A1 (en) | 2015-06-30 | 2017-01-05 | Kaleo, Inc. | Auto-injectors for administration of a medicament within a prefilled syringe |
CA2993275C (en) | 2015-08-20 | 2022-06-21 | Aseko, Inc. | Diabetes management therapy advisor |
GB201517089D0 (en) | 2015-09-28 | 2015-11-11 | Nicoventures Holdings Ltd | Vaping heat map system and method for electronic vapour provision systems |
US10255412B2 (en) | 2015-11-13 | 2019-04-09 | Reciprocal Labs Corporation | Real time adaptive controller medication dosing |
US9737254B2 (en) | 2015-11-23 | 2017-08-22 | Novtex Llc | Personal medical testing housing |
JP2019509770A (en) | 2016-01-05 | 2019-04-11 | ビッグフット バイオメディカル インコーポレイテッドBigfoot Biomedical, Inc. | A working multimodal drug delivery system |
US10449294B1 (en) | 2016-01-05 | 2019-10-22 | Bigfoot Biomedical, Inc. | Operating an infusion pump system |
EP3374905A1 (en) | 2016-01-13 | 2018-09-19 | Bigfoot Biomedical, Inc. | User interface for diabetes management system |
CN112933333B (en) | 2016-01-14 | 2023-03-28 | 比格福特生物医药公司 | Adjusting insulin delivery rate |
USD809134S1 (en) | 2016-03-10 | 2018-01-30 | Bigfoot Biomedical, Inc. | Infusion pump assembly |
US10857304B2 (en) | 2016-03-25 | 2020-12-08 | Eli Lilly And Company | Determination of a dose set and delivered in a medication delivery device |
WO2017184401A1 (en) | 2016-04-19 | 2017-10-26 | Eli Lilly And Company | Determination of a dose in a medication delivery device using two moving arrays with teeth and a sensor |
WO2017197024A1 (en) | 2016-05-13 | 2017-11-16 | Icu Medical, Inc. | Infusion pump system and method with common line auto flush |
BR112018073742B1 (en) | 2016-05-19 | 2023-12-26 | Mannkind Corporation | INHALER ACCESSORY APPARATUS, MONITORING AND DETECTION SYSTEM, AND MONITORING AND DETECTION METHOD |
CA3027176A1 (en) | 2016-06-10 | 2017-12-14 | Icu Medical, Inc. | Acoustic flow sensor for continuous medication flow measurements and feedback control of infusion |
EP3484541A4 (en) | 2016-07-14 | 2020-03-25 | ICU Medical, Inc. | Multi-communication path selection and security system for a medical device |
WO2018031390A1 (en) | 2016-08-12 | 2018-02-15 | Eli Lilly And Company | Dose sensing mechanism in a medication delivery device |
EP3515535A1 (en) | 2016-09-23 | 2019-07-31 | Insulet Corporation | Fluid delivery device with sensor |
CN110675949A (en) | 2016-09-27 | 2020-01-10 | 比格福特生物医药公司 | Drug injection and disease management systems, devices and methods |
USD836769S1 (en) | 2016-12-12 | 2018-12-25 | Bigfoot Biomedical, Inc. | Insulin delivery controller |
US11096624B2 (en) | 2016-12-12 | 2021-08-24 | Bigfoot Biomedical, Inc. | Alarms and alerts for medication delivery devices and systems |
US20190314581A1 (en) | 2016-12-15 | 2019-10-17 | Eli Lilly And Company | Medication delivery device with sensing system |
US10332623B2 (en) | 2017-01-17 | 2019-06-25 | Kaleo, Inc. | Medicament delivery devices with wireless connectivity and event detection |
USD839294S1 (en) | 2017-06-16 | 2019-01-29 | Bigfoot Biomedical, Inc. | Display screen with graphical user interface for closed-loop medication delivery |
WO2019014594A1 (en) | 2017-07-13 | 2019-01-17 | Desborough Lane | Multi-scale display of blood glucose information |
US10089055B1 (en) | 2017-12-27 | 2018-10-02 | Icu Medical, Inc. | Synchronized display of screen content on networked devices |
US11804303B2 (en) | 2018-03-01 | 2023-10-31 | Reciprocal Labs Corporation | Evaluation of respiratory disease risk in a geographic region based on medicament device monitoring |
JP7124120B2 (en) | 2018-05-04 | 2022-08-23 | インスレット コーポレイション | Safety Constraints for Control Algorithm-Based Drug Delivery Systems |
WO2020018433A1 (en) | 2018-07-16 | 2020-01-23 | Kaleo, Inc. | Medicament delivery devices with wireless connectivity and compliance detection |
WO2020018389A1 (en) | 2018-07-17 | 2020-01-23 | Icu Medical, Inc. | Systems and methods for facilitating clinical messaging in a network environment |
US10861592B2 (en) | 2018-07-17 | 2020-12-08 | Icu Medical, Inc. | Reducing infusion pump network congestion by staggering updates |
EP3824386B1 (en) | 2018-07-17 | 2024-02-21 | ICU Medical, Inc. | Updating infusion pump drug libraries and operational software in a networked environment |
US10741280B2 (en) | 2018-07-17 | 2020-08-11 | Icu Medical, Inc. | Tagging pump messages with identifiers that facilitate restructuring |
EP3827337A4 (en) | 2018-07-26 | 2022-04-13 | ICU Medical, Inc. | Drug library management system |
US10692595B2 (en) | 2018-07-26 | 2020-06-23 | Icu Medical, Inc. | Drug library dynamic version management |
EP3856285A1 (en) | 2018-09-28 | 2021-08-04 | Insulet Corporation | Activity mode for artificial pancreas system |
EP3864668A1 (en) | 2018-10-11 | 2021-08-18 | Insulet Corporation | Event detection for drug delivery system |
USD930972S1 (en) * | 2018-11-02 | 2021-09-21 | Ondosis Ab | Tablet dispenser for medications |
CA3145580A1 (en) | 2019-08-09 | 2021-02-18 | Kaleo, Inc. | Devices and methods for delivery of substances within a prefilled syringe |
US11801344B2 (en) | 2019-09-13 | 2023-10-31 | Insulet Corporation | Blood glucose rate of change modulation of meal and correction insulin bolus quantity |
US11935637B2 (en) | 2019-09-27 | 2024-03-19 | Insulet Corporation | Onboarding and total daily insulin adaptivity |
JP1669717S (en) * | 2019-11-07 | 2020-10-05 | tablet dispenser | |
US11278671B2 (en) | 2019-12-04 | 2022-03-22 | Icu Medical, Inc. | Infusion pump with safety sequence keypad |
WO2021113647A1 (en) | 2019-12-06 | 2021-06-10 | Insulet Corporation | Techniques and devices providing adaptivity and personalization in diabetes treatment |
US11833329B2 (en) | 2019-12-20 | 2023-12-05 | Insulet Corporation | Techniques for improved automatic drug delivery performance using delivery tendencies from past delivery history and use patterns |
US11551802B2 (en) | 2020-02-11 | 2023-01-10 | Insulet Corporation | Early meal detection and calorie intake detection |
US11547800B2 (en) | 2020-02-12 | 2023-01-10 | Insulet Corporation | User parameter dependent cost function for personalized reduction of hypoglycemia and/or hyperglycemia in a closed loop artificial pancreas system |
US11324889B2 (en) | 2020-02-14 | 2022-05-10 | Insulet Corporation | Compensation for missing readings from a glucose monitor in an automated insulin delivery system |
US20210251572A1 (en) * | 2020-02-16 | 2021-08-19 | Shimmer Research Ltd | Wearable data collection device |
US11607493B2 (en) | 2020-04-06 | 2023-03-21 | Insulet Corporation | Initial total daily insulin setting for user onboarding |
WO2022020184A1 (en) | 2020-07-21 | 2022-01-27 | Icu Medical, Inc. | Fluid transfer devices and methods of use |
US11684716B2 (en) | 2020-07-31 | 2023-06-27 | Insulet Corporation | Techniques to reduce risk of occlusions in drug delivery systems |
US11135360B1 (en) | 2020-12-07 | 2021-10-05 | Icu Medical, Inc. | Concurrent infusion with common line auto flush |
US11904140B2 (en) | 2021-03-10 | 2024-02-20 | Insulet Corporation | Adaptable asymmetric medicament cost component in a control system for medicament delivery |
US11738144B2 (en) | 2021-09-27 | 2023-08-29 | Insulet Corporation | Techniques enabling adaptation of parameters in aid systems by user input |
US11439754B1 (en) | 2021-12-01 | 2022-09-13 | Insulet Corporation | Optimizing embedded formulations for drug delivery |
Citations (7)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US4494950A (en) * | 1982-01-19 | 1985-01-22 | The Johns Hopkins University | Plural module medication delivery system |
US5665065A (en) * | 1995-05-26 | 1997-09-09 | Minimed Inc. | Medication infusion device with blood glucose data input |
US5687717A (en) * | 1996-08-06 | 1997-11-18 | Tremont Medical, Inc. | Patient monitoring system with chassis mounted or remotely operable modules and portable computer |
US5772586A (en) * | 1996-02-12 | 1998-06-30 | Nokia Mobile Phones, Ltd. | Method for monitoring the health of a patient |
US6218958B1 (en) * | 1998-10-08 | 2001-04-17 | International Business Machines Corporation | Integrated touch-skin notification system for wearable computing devices |
US6302855B1 (en) * | 1998-05-20 | 2001-10-16 | Novo Nordisk A/S | Medical apparatus for use by a patient for medical self treatment of diabetes |
US6540672B1 (en) * | 1998-12-09 | 2003-04-01 | Novo Nordisk A/S | Medical system and a method of controlling the system for use by a patient for medical self treatment |
Family Cites Families (12)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US3786510A (en) * | 1972-07-26 | 1974-01-15 | F Hodges | Medical testing and data recording apparatus |
FR2483657B1 (en) * | 1980-05-30 | 1986-11-21 | Bull Sa | PORTABLE MACHINE FOR CALCULATING OR PROCESSING INFORMATION |
US5204670A (en) | 1988-08-29 | 1993-04-20 | B. I. Incorporated | Adaptable electric monitoring and identification system |
SE500122C2 (en) * | 1992-08-27 | 1994-04-18 | Rudolf Valentin Sillen | Method and apparatus for individually controlled, adaptive medication |
US5371687A (en) * | 1992-11-20 | 1994-12-06 | Boehringer Mannheim Corporation | Glucose test data acquisition and management system |
US5313941A (en) * | 1993-01-28 | 1994-05-24 | Braig James R | Noninvasive pulsed infrared spectrophotometer |
US5536249A (en) * | 1994-03-09 | 1996-07-16 | Visionary Medical Products, Inc. | Pen-type injector with a microprocessor and blood characteristic monitor |
US5704366A (en) * | 1994-05-23 | 1998-01-06 | Enact Health Management Systems | System for monitoring and reporting medical measurements |
US5752976A (en) * | 1995-06-23 | 1998-05-19 | Medtronic, Inc. | World wide patient location and data telemetry system for implantable medical devices |
US5842976A (en) * | 1996-05-16 | 1998-12-01 | Pyxis Corporation | Dispensing, storage, control and inventory system with medication and treatment chart record |
DE69715255T2 (en) | 1996-07-16 | 2003-05-08 | Kyoto Daiichi Kagaku Kk | DISTRIBUTED MONITORING / MEASURING ARRANGEMENT FOR HEALTHCARE |
US6363416B1 (en) * | 1998-08-28 | 2002-03-26 | 3Com Corporation | System and method for automatic election of a representative node within a communications network with built-in redundancy |
-
1999
- 1999-11-29 US US09/450,193 patent/US6540672B1/en not_active Expired - Lifetime
-
2003
- 2003-01-14 US US10/342,150 patent/US20040039255A1/en not_active Abandoned
Patent Citations (7)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US4494950A (en) * | 1982-01-19 | 1985-01-22 | The Johns Hopkins University | Plural module medication delivery system |
US5665065A (en) * | 1995-05-26 | 1997-09-09 | Minimed Inc. | Medication infusion device with blood glucose data input |
US5772586A (en) * | 1996-02-12 | 1998-06-30 | Nokia Mobile Phones, Ltd. | Method for monitoring the health of a patient |
US5687717A (en) * | 1996-08-06 | 1997-11-18 | Tremont Medical, Inc. | Patient monitoring system with chassis mounted or remotely operable modules and portable computer |
US6302855B1 (en) * | 1998-05-20 | 2001-10-16 | Novo Nordisk A/S | Medical apparatus for use by a patient for medical self treatment of diabetes |
US6218958B1 (en) * | 1998-10-08 | 2001-04-17 | International Business Machines Corporation | Integrated touch-skin notification system for wearable computing devices |
US6540672B1 (en) * | 1998-12-09 | 2003-04-01 | Novo Nordisk A/S | Medical system and a method of controlling the system for use by a patient for medical self treatment |
Cited By (175)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US8715177B2 (en) * | 2000-10-06 | 2014-05-06 | Ip Holdings, Inc. | Intelligent drug delivery appliance |
US7072738B2 (en) | 2001-04-02 | 2006-07-04 | Glaxo Group Limited | Medicament dispenser |
US7454267B2 (en) | 2001-04-02 | 2008-11-18 | Glaxo Group Limited | Medicament dispenser |
US11294407B2 (en) | 2001-04-27 | 2022-04-05 | Roche Diabetes Care, Inc. | Device and method for insulin dosing |
US10039881B2 (en) | 2002-12-31 | 2018-08-07 | Abbott Diabetes Care Inc. | Method and system for providing data communication in continuous glucose monitoring and management system |
US9962091B2 (en) | 2002-12-31 | 2018-05-08 | Abbott Diabetes Care Inc. | Continuous glucose monitoring system and methods of use |
US10750952B2 (en) | 2002-12-31 | 2020-08-25 | Abbott Diabetes Care Inc. | Continuous glucose monitoring system and methods of use |
US9730584B2 (en) | 2003-06-10 | 2017-08-15 | Abbott Diabetes Care Inc. | Glucose measuring device for use in personal area network |
US8512239B2 (en) * | 2003-06-10 | 2013-08-20 | Abbott Diabetes Care Inc. | Glucose measuring device for use in personal area network |
US20090284372A1 (en) * | 2003-06-10 | 2009-11-19 | Abbott Diabetes Care Inc. | Glucose Measuring Device For Use In Personal Area Network |
US20050182358A1 (en) * | 2003-11-06 | 2005-08-18 | Veit Eric D. | Drug delivery pen with event notification means |
US7713229B2 (en) | 2003-11-06 | 2010-05-11 | Lifescan, Inc. | Drug delivery pen with event notification means |
US20110184343A1 (en) * | 2003-11-06 | 2011-07-28 | Lifescan, Inc. | Drug delivery with event notification |
US8333752B2 (en) | 2003-11-06 | 2012-12-18 | Lifescan, Inc. | Drug delivery with event notification |
US8551039B2 (en) | 2003-11-06 | 2013-10-08 | Lifescan, Inc. | Drug delivery with event notification |
US20050182306A1 (en) * | 2004-02-17 | 2005-08-18 | Therasense, Inc. | Method and system for providing data communication in continuous glucose monitoring and management system |
US8771183B2 (en) | 2004-02-17 | 2014-07-08 | Abbott Diabetes Care Inc. | Method and system for providing data communication in continuous glucose monitoring and management system |
US20080270186A1 (en) * | 2004-08-24 | 2008-10-30 | Soren Mikkelsen | Giving a Service to a Patient |
WO2006021566A3 (en) * | 2004-08-24 | 2006-07-27 | Novo Nordisk As | Giving a service to a patient |
WO2006021566A2 (en) * | 2004-08-24 | 2006-03-02 | Novo Nordisk A/S | Giving a service to a patient |
US8202217B2 (en) | 2004-12-20 | 2012-06-19 | Ip Venture, Inc. | Healthcare base |
US20060231109A1 (en) * | 2004-12-20 | 2006-10-19 | Howell Thomas A | Personal and portable bottle |
US8118740B2 (en) | 2004-12-20 | 2012-02-21 | Ipventure, Inc. | Moisture sensor for skin |
US8652037B2 (en) | 2005-06-08 | 2014-02-18 | AgaMatrix, LLC | Data collection system and interface |
US20060279431A1 (en) * | 2005-06-08 | 2006-12-14 | Agamatrix, Inc. | Data collection system and interface |
US20070078818A1 (en) * | 2005-06-09 | 2007-04-05 | Roche Diagnostics Operations, Inc. | Device and method for insulin dosing |
US10311209B2 (en) | 2005-06-09 | 2019-06-04 | Roche Diabetes Care, Inc. | Device and method for insulin dosing |
US8251904B2 (en) | 2005-06-09 | 2012-08-28 | Roche Diagnostics Operations, Inc. | Device and method for insulin dosing |
US20100274220A1 (en) * | 2005-11-04 | 2010-10-28 | Abbott Diabetes Care Inc. | Method and System for Providing Basal Profile Modification in Analyte Monitoring and Management Systems |
US8585591B2 (en) | 2005-11-04 | 2013-11-19 | Abbott Diabetes Care Inc. | Method and system for providing basal profile modification in analyte monitoring and management systems |
US11538580B2 (en) | 2005-11-04 | 2022-12-27 | Abbott Diabetes Care Inc. | Method and system for providing basal profile modification in analyte monitoring and management systems |
US9669162B2 (en) | 2005-11-04 | 2017-06-06 | Abbott Diabetes Care Inc. | Method and system for providing basal profile modification in analyte monitoring and management systems |
US9323898B2 (en) | 2005-11-04 | 2016-04-26 | Abbott Diabetes Care Inc. | Method and system for providing basal profile modification in analyte monitoring and management systems |
US20070142767A1 (en) * | 2005-12-12 | 2007-06-21 | Marcel Frikart | System with A Portable Patient Device and External Operating Part |
US8758240B2 (en) * | 2005-12-12 | 2014-06-24 | Roche Diagnostics International Ag | System with a portable patient device and external operating part |
US8112293B2 (en) | 2006-03-24 | 2012-02-07 | Ipventure, Inc | Medical monitoring system |
US20070225578A1 (en) * | 2006-03-24 | 2007-09-27 | Howell Thomas A | Medical monitoring system |
US9039975B2 (en) | 2006-03-31 | 2015-05-26 | Abbott Diabetes Care Inc. | Analyte monitoring devices and methods therefor |
US8593109B2 (en) | 2006-03-31 | 2013-11-26 | Abbott Diabetes Care Inc. | Method and system for powering an electronic device |
US8597575B2 (en) | 2006-03-31 | 2013-12-03 | Abbott Diabetes Care Inc. | Analyte monitoring devices and methods therefor |
US9625413B2 (en) | 2006-03-31 | 2017-04-18 | Abbott Diabetes Care Inc. | Analyte monitoring devices and methods therefor |
US8933664B2 (en) | 2006-03-31 | 2015-01-13 | Abbott Diabetes Care Inc. | Method and system for powering an electronic device |
US9380971B2 (en) | 2006-03-31 | 2016-07-05 | Abbott Diabetes Care Inc. | Method and system for powering an electronic device |
US9743863B2 (en) | 2006-03-31 | 2017-08-29 | Abbott Diabetes Care Inc. | Method and system for powering an electronic device |
AU2007234940B2 (en) * | 2006-04-03 | 2013-05-09 | Trividia Health, Inc. | Diagnostic meter |
US8696597B2 (en) * | 2006-04-03 | 2014-04-15 | Nipro Diagnostics, Inc. | Diagnostic meter |
US20070233395A1 (en) * | 2006-04-03 | 2007-10-04 | Home Diagnostics, Inc. | Diagnostic meter |
US20080177149A1 (en) * | 2006-06-16 | 2008-07-24 | Stefan Weinert | System and method for collecting patient information from which diabetes therapy may be determined |
US20090105571A1 (en) * | 2006-06-30 | 2009-04-23 | Abbott Diabetes Care, Inc. | Method and System for Providing Data Communication in Data Management Systems |
US7434724B2 (en) | 2006-12-22 | 2008-10-14 | Welch Allyn, Inc. | Dynamic barcode for displaying medical data |
US10022499B2 (en) | 2007-02-15 | 2018-07-17 | Abbott Diabetes Care Inc. | Device and method for automatic data acquisition and/or detection |
US10617823B2 (en) | 2007-02-15 | 2020-04-14 | Abbott Diabetes Care Inc. | Device and method for automatic data acquisition and/or detection |
US9095290B2 (en) | 2007-03-01 | 2015-08-04 | Abbott Diabetes Care Inc. | Method and apparatus for providing rolling data in communication systems |
US9801545B2 (en) | 2007-03-01 | 2017-10-31 | Abbott Diabetes Care Inc. | Method and apparatus for providing rolling data in communication systems |
US8698615B2 (en) | 2007-04-14 | 2014-04-15 | Abbott Diabetes Care Inc. | Method and apparatus for providing dynamic multi-stage signal amplification in a medical device |
US9402584B2 (en) | 2007-04-14 | 2016-08-02 | Abbott Diabetes Care Inc. | Method and apparatus for providing dynamic multi-stage signal amplification in a medical device |
US9743866B2 (en) | 2007-04-14 | 2017-08-29 | Abbott Diabetes Care Inc. | Method and apparatus for providing dynamic multi-stage signal amplification in a medical device |
US10194846B2 (en) | 2007-04-14 | 2019-02-05 | Abbott Diabetes Care Inc. | Method and apparatus for providing dynamic multi-stage signal amplification in a medical device |
US8937540B2 (en) | 2007-04-14 | 2015-01-20 | Abbott Diabetes Care Inc. | Method and apparatus for providing dynamic multi-stage signal amplification in a medical device |
US9649057B2 (en) | 2007-05-08 | 2017-05-16 | Abbott Diabetes Care Inc. | Analyte monitoring system and methods |
US10178954B2 (en) | 2007-05-08 | 2019-01-15 | Abbott Diabetes Care Inc. | Analyte monitoring system and methods |
US20080281179A1 (en) * | 2007-05-08 | 2008-11-13 | Abbott Diabetes Care, Inc. | Analyte monitoring system and methods |
US8593287B2 (en) | 2007-05-08 | 2013-11-26 | Abbott Diabetes Care Inc. | Analyte monitoring system and methods |
US9949678B2 (en) | 2007-05-08 | 2018-04-24 | Abbott Diabetes Care Inc. | Method and device for determining elapsed sensor life |
US20080278332A1 (en) * | 2007-05-08 | 2008-11-13 | Abbott Diabetes Care, Inc. | Analyte monitoring system and methods |
US8461985B2 (en) | 2007-05-08 | 2013-06-11 | Abbott Diabetes Care Inc. | Analyte monitoring system and methods |
US10952611B2 (en) | 2007-05-08 | 2021-03-23 | Abbott Diabetes Care Inc. | Analyte monitoring system and methods |
US9000929B2 (en) | 2007-05-08 | 2015-04-07 | Abbott Diabetes Care Inc. | Analyte monitoring system and methods |
US9035767B2 (en) | 2007-05-08 | 2015-05-19 | Abbott Diabetes Care Inc. | Analyte monitoring system and methods |
US8456301B2 (en) | 2007-05-08 | 2013-06-04 | Abbott Diabetes Care Inc. | Analyte monitoring system and methods |
US10653317B2 (en) | 2007-05-08 | 2020-05-19 | Abbott Diabetes Care Inc. | Analyte monitoring system and methods |
US9574914B2 (en) | 2007-05-08 | 2017-02-21 | Abbott Diabetes Care Inc. | Method and device for determining elapsed sensor life |
US9177456B2 (en) | 2007-05-08 | 2015-11-03 | Abbott Diabetes Care Inc. | Analyte monitoring system and methods |
US11696684B2 (en) | 2007-05-08 | 2023-07-11 | Abbott Diabetes Care Inc. | Analyte monitoring system and methods |
US9314198B2 (en) | 2007-05-08 | 2016-04-19 | Abbott Diabetes Care Inc. | Analyte monitoring system and methods |
US20100076290A1 (en) * | 2007-06-21 | 2010-03-25 | Abbott Diabetes Care Inc. | Health Monitor |
US20100076284A1 (en) * | 2007-06-21 | 2010-03-25 | Abbott Diabetes Care Inc. | Health Management Devices and Methods |
US20100076289A1 (en) * | 2007-06-21 | 2010-03-25 | Abbott Diabetes Care Inc. | Health Monitor |
US11264133B2 (en) | 2007-06-21 | 2022-03-01 | Abbott Diabetes Care Inc. | Health management devices and methods |
US8597188B2 (en) | 2007-06-21 | 2013-12-03 | Abbott Diabetes Care Inc. | Health management devices and methods |
US20080319296A1 (en) * | 2007-06-21 | 2008-12-25 | Abbott Diabetes Care, Inc. | Health monitor |
US20100076291A1 (en) * | 2007-06-21 | 2010-03-25 | Abbott Diabetes Care Inc. | Health Monitor |
US8617069B2 (en) | 2007-06-21 | 2013-12-31 | Abbott Diabetes Care Inc. | Health monitor |
US20100076280A1 (en) * | 2007-06-21 | 2010-03-25 | Abbott Diabetes Care Inc. | Health Monitor |
US11276492B2 (en) | 2007-06-21 | 2022-03-15 | Abbott Diabetes Care Inc. | Health management devices and methods |
US8546328B2 (en) * | 2007-08-27 | 2013-10-01 | Biogenerix Ag | Liquid formulation of G-CSF conjugate |
US20110053844A1 (en) * | 2007-08-27 | 2011-03-03 | Walter Hinderer | Liquid formulation of g-csf conjugate |
USD612279S1 (en) | 2008-01-18 | 2010-03-23 | Lifescan Scotland Limited | User interface in an analyte meter |
USD612274S1 (en) | 2008-01-18 | 2010-03-23 | Lifescan Scotland, Ltd. | User interface in an analyte meter |
US20090237262A1 (en) * | 2008-03-21 | 2009-09-24 | Lifescan Scotland Ltd. | Analyte testing method and system |
US8917184B2 (en) | 2008-03-21 | 2014-12-23 | Lifescan Scotland Limited | Analyte testing method and system |
USD615431S1 (en) | 2008-03-21 | 2010-05-11 | Lifescan Scotland Limited | Analyte test meter |
USD612275S1 (en) | 2008-03-21 | 2010-03-23 | Lifescan Scotland, Ltd. | Analyte test meter |
USD611853S1 (en) | 2008-03-21 | 2010-03-16 | Lifescan Scotland Limited | Analyte test meter |
US9626480B2 (en) | 2008-03-21 | 2017-04-18 | Lifescan Scotland Limited | Analyte testing method and system |
USD611151S1 (en) | 2008-06-10 | 2010-03-02 | Lifescan Scotland, Ltd. | Test meter |
USD611489S1 (en) | 2008-07-25 | 2010-03-09 | Lifescan, Inc. | User interface display for a glucose meter |
USD611372S1 (en) | 2008-09-19 | 2010-03-09 | Lifescan Scotland Limited | Analyte test meter |
US11202591B2 (en) | 2009-02-03 | 2021-12-21 | Abbott Diabetes Care Inc. | Analyte sensor and apparatus for insertion of the sensor |
US11166656B2 (en) | 2009-02-03 | 2021-11-09 | Abbott Diabetes Care Inc. | Analyte sensor and apparatus for insertion of the sensor |
US11006871B2 (en) | 2009-02-03 | 2021-05-18 | Abbott Diabetes Care Inc. | Analyte sensor and apparatus for insertion of the sensor |
US11213229B2 (en) | 2009-02-03 | 2022-01-04 | Abbott Diabetes Care Inc. | Analyte sensor and apparatus for insertion of the sensor |
US11006870B2 (en) | 2009-02-03 | 2021-05-18 | Abbott Diabetes Care Inc. | Analyte sensor and apparatus for insertion of the sensor |
US11006872B2 (en) | 2009-02-03 | 2021-05-18 | Abbott Diabetes Care Inc. | Analyte sensor and apparatus for insertion of the sensor |
US9226701B2 (en) | 2009-04-28 | 2016-01-05 | Abbott Diabetes Care Inc. | Error detection in critical repeating data in a wireless sensor system |
US11872370B2 (en) | 2009-05-29 | 2024-01-16 | Abbott Diabetes Care Inc. | Medical device antenna systems having external antenna configurations |
US11793936B2 (en) | 2009-05-29 | 2023-10-24 | Abbott Diabetes Care Inc. | Medical device antenna systems having external antenna configurations |
US20110054282A1 (en) * | 2009-08-31 | 2011-03-03 | Abbott Diabetes Care Inc. | Analyte Monitoring System and Methods for Managing Power and Noise |
US10429250B2 (en) | 2009-08-31 | 2019-10-01 | Abbott Diabetes Care, Inc. | Analyte monitoring system and methods for managing power and noise |
US11150145B2 (en) | 2009-08-31 | 2021-10-19 | Abbott Diabetes Care Inc. | Analyte monitoring system and methods for managing power and noise |
US10492685B2 (en) | 2009-08-31 | 2019-12-03 | Abbott Diabetes Care Inc. | Medical devices and methods |
US11045147B2 (en) | 2009-08-31 | 2021-06-29 | Abbott Diabetes Care Inc. | Analyte signal processing device and methods |
USD1010133S1 (en) | 2009-08-31 | 2024-01-02 | Abbott Diabetes Care Inc. | Analyte sensor assembly |
US9314195B2 (en) | 2009-08-31 | 2016-04-19 | Abbott Diabetes Care Inc. | Analyte signal processing device and methods |
US9968302B2 (en) | 2009-08-31 | 2018-05-15 | Abbott Diabetes Care Inc. | Analyte signal processing device and methods |
US20110060530A1 (en) * | 2009-08-31 | 2011-03-10 | Abbott Diabetes Care Inc. | Analyte Signal Processing Device and Methods |
US10136816B2 (en) | 2009-08-31 | 2018-11-27 | Abbott Diabetes Care Inc. | Medical devices and methods |
US11635332B2 (en) | 2009-08-31 | 2023-04-25 | Abbott Diabetes Care Inc. | Analyte monitoring system and methods for managing power and noise |
US8993331B2 (en) | 2009-08-31 | 2015-03-31 | Abbott Diabetes Care Inc. | Analyte monitoring system and methods for managing power and noise |
US10639502B2 (en) | 2010-10-12 | 2020-05-05 | Smith & Nephew, Inc. | Medical device |
US9526920B2 (en) | 2010-10-12 | 2016-12-27 | Smith & Nephew, Inc. | Medical device |
US11565134B2 (en) | 2010-10-12 | 2023-01-31 | Smith & Nephew, Inc. | Medical device |
US10086216B2 (en) | 2010-10-12 | 2018-10-02 | Smith & Nephew, Inc. | Medical device |
US9532737B2 (en) | 2011-02-28 | 2017-01-03 | Abbott Diabetes Care Inc. | Devices, systems, and methods associated with analyte monitoring devices and devices incorporating the same |
US9465420B2 (en) | 2011-10-31 | 2016-10-11 | Abbott Diabetes Care Inc. | Electronic devices having integrated reset systems and methods thereof |
US9069536B2 (en) | 2011-10-31 | 2015-06-30 | Abbott Diabetes Care Inc. | Electronic devices having integrated reset systems and methods thereof |
US9980669B2 (en) | 2011-11-07 | 2018-05-29 | Abbott Diabetes Care Inc. | Analyte monitoring device and methods |
US11612363B2 (en) | 2012-09-17 | 2023-03-28 | Abbott Diabetes Care Inc. | Methods and apparatuses for providing adverse condition notification with enhanced wireless communication range in analyte monitoring systems |
US9968306B2 (en) | 2012-09-17 | 2018-05-15 | Abbott Diabetes Care Inc. | Methods and apparatuses for providing adverse condition notification with enhanced wireless communication range in analyte monitoring systems |
US11950936B2 (en) | 2012-09-17 | 2024-04-09 | Abbott Diabetes Care Inc. | Methods and apparatuses for providing adverse condition notification with enhanced wireless communication range in analyte monitoring systems |
US11633533B2 (en) | 2013-03-14 | 2023-04-25 | Smith & Nephew, Inc. | Control architecture for reduced pressure wound therapy apparatus |
US10610624B2 (en) | 2013-03-14 | 2020-04-07 | Smith & Nephew, Inc. | Reduced pressure therapy blockage detection |
US10905806B2 (en) | 2013-03-14 | 2021-02-02 | Smith & Nephew, Inc. | Reduced pressure wound therapy control and data communication |
US10328188B2 (en) | 2013-03-14 | 2019-06-25 | Smith & Nephew, Inc. | Systems and methods for applying reduced pressure therapy |
US9737649B2 (en) | 2013-03-14 | 2017-08-22 | Smith & Nephew, Inc. | Systems and methods for applying reduced pressure therapy |
US10912870B2 (en) | 2013-08-13 | 2021-02-09 | Smith & Nephew, Inc. | Canister fluid level detection in reduced pressure therapy systems |
US10155070B2 (en) | 2013-08-13 | 2018-12-18 | Smith & Nephew, Inc. | Systems and methods for applying reduced pressure therapy |
US10754927B2 (en) | 2013-09-26 | 2020-08-25 | Companion Medical, Inc. | System for administering a medicament |
US10483000B2 (en) | 2014-07-10 | 2019-11-19 | Companion Medical, Inc. | Medicine administering system including injection pen and companion device |
WO2016007935A3 (en) * | 2014-07-10 | 2016-04-07 | Companion Medical, Inc. | Medicine administering system including injection pen and companion device |
US9959391B2 (en) | 2014-07-10 | 2018-05-01 | Companion Medical, Inc. | Medicine administering system including injection pen and companion device |
US11563485B2 (en) | 2014-07-10 | 2023-01-24 | Medtronic Minimed, Inc. | Medicine administering system including injection pen and companion device |
US10744239B2 (en) | 2014-07-31 | 2020-08-18 | Smith & Nephew, Inc. | Leak detection in negative pressure wound therapy system |
US11524106B2 (en) | 2014-12-30 | 2022-12-13 | Smith & Nephew, Inc. | Blockage detection in reduced pressure therapy |
US10556045B2 (en) | 2014-12-30 | 2020-02-11 | Smith & Nephew, Inc. | Synchronous pressure sampling and supply of negative pressure in negative pressure wound therapy |
US10549016B2 (en) | 2014-12-30 | 2020-02-04 | Smith & Nephew, Inc. | Blockage detection in reduced pressure therapy |
US11783943B2 (en) | 2015-10-07 | 2023-10-10 | Smith & Nephew, Inc. | Reduced pressure therapy device operation and authorization monitoring |
US11315681B2 (en) | 2015-10-07 | 2022-04-26 | Smith & Nephew, Inc. | Reduced pressure therapy device operation and authorization monitoring |
US11826555B2 (en) | 2016-01-29 | 2023-11-28 | Medtronic Minimed, Inc. | Automatic medication delivery tracking |
US10864327B2 (en) | 2016-01-29 | 2020-12-15 | Companion Medical, Inc. | Automatic medication delivery tracking |
US11602461B2 (en) | 2016-05-13 | 2023-03-14 | Smith & Nephew, Inc. | Automatic wound coupling detection in negative pressure wound therapy systems |
US11484657B2 (en) | 2017-06-09 | 2022-11-01 | Medtronic Minimed, Inc. | Intelligent medication delivery systems and methods |
US11568975B2 (en) | 2017-10-12 | 2023-01-31 | Medtronic Minimed, Inc. | Intelligent medication delivery systems and methods for dose recommendation and management |
US11931549B2 (en) | 2017-12-12 | 2024-03-19 | Bigfoot Biomedical, Inc. | User interface for diabetes management systems and devices |
US11896797B2 (en) | 2017-12-12 | 2024-02-13 | Bigfoot Biomedical, Inc. | Pen cap for insulin injection pens and associated methods and systems |
US11383043B2 (en) | 2017-12-12 | 2022-07-12 | Bigfoot Biomedical, Inc. | Medicine injection and disease management systems, devices, and methods |
US11918789B2 (en) | 2017-12-12 | 2024-03-05 | Bigfoot Biomedical, Inc. | Therapy management systems, methods, and devices |
US11904145B2 (en) | 2017-12-12 | 2024-02-20 | Bigfoot Biomedical, Inc. | Diabetes therapy management systems, methods, and devices |
US11547805B2 (en) | 2017-12-12 | 2023-01-10 | Bigfoot Biomedical, Inc. | Therapy management systems, methods, and devices |
US11771835B2 (en) | 2017-12-12 | 2023-10-03 | Bigfoot Biomedical, Inc. | Therapy assist information and/or tracking device and related methods and systems |
US11957884B2 (en) | 2017-12-12 | 2024-04-16 | Bigfoot Biomedical, Inc. | Insulin injection assistance systems, methods, and devices |
US11944465B2 (en) | 2017-12-12 | 2024-04-02 | Bigfoot Biomedical, Inc. | Monitor user interface for diabetes management systems including flash glucose |
US11464459B2 (en) | 2017-12-12 | 2022-10-11 | Bigfoot Biomedical, Inc. | User interface for diabetes management systems including flash glucose monitor |
US11844923B2 (en) | 2017-12-12 | 2023-12-19 | Bigfoot Biomedical, Inc. | Devices, systems, and methods for estimating active medication from injections |
US11369743B2 (en) | 2018-05-08 | 2022-06-28 | Companion Medical, Inc. | Intelligent medication delivery systems and methods for dose setting and dispensing monitoring |
US11878151B2 (en) | 2018-05-08 | 2024-01-23 | Medtronic Minimed, Inc. | Intelligent medication delivery systems and methods for dose setting and dispensing monitoring |
US10898653B2 (en) | 2018-05-08 | 2021-01-26 | Companion Medical, Inc. | Intelligent medication delivery systems and methods for dose setting and dispensing monitoring |
US11664107B2 (en) | 2018-05-08 | 2023-05-30 | Medtronic Minimed, Inc. | Intelligent medication delivery systems and methods using a prescription-regulated software application |
USD908210S1 (en) | 2018-05-11 | 2021-01-19 | Companion Medical, Inc. | Injection pen |
USD893020S1 (en) | 2018-05-11 | 2020-08-11 | Companion Medical, Inc. | Injection pen |
US11587663B2 (en) | 2018-06-20 | 2023-02-21 | Medtronic Minimed, Inc. | Intelligent medication delivery systems and methods for medicine dose calculation and reporting |
USD892819S1 (en) | 2018-06-20 | 2020-08-11 | Companion Medical, Inc. | Display screen with graphical user interface |
USD960895S1 (en) | 2018-06-20 | 2022-08-16 | Medtronic Minimed, Inc. | Display screen with graphical user interface |
US11948671B2 (en) | 2019-04-11 | 2024-04-02 | Medtronic Minimed, Inc. | Intelligent accessories for medicine dispensing device |
US11701473B2 (en) | 2021-06-23 | 2023-07-18 | Medtronic Minimed, Inc. | Reusable injection pens |
Also Published As
Publication number | Publication date |
---|---|
US6540672B1 (en) | 2003-04-01 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
US20040039255A1 (en) | Medical system and a method of controlling the system for use by a patient for medical self treatment | |
AU763478B2 (en) | A medical system and a method of controlling the system for use by a patient for medical self treatment | |
US20070293742A1 (en) | Medical System And A Method Of Controlling The System For Use By A Patient For Medical Self Treatment | |
EP1406540B1 (en) | Method and system for controlling data information between two portable medical apparatuses | |
AU2002351605B2 (en) | Method and apparatus for clinical trials | |
US8551039B2 (en) | Drug delivery with event notification | |
KR100627990B1 (en) | A method and a system for assisting a user in a medical self treatment, said self treatment comprising a plurality of actions | |
US20080228057A1 (en) | Method and system for controlling data information between two portable apparatuses | |
AU2002354523A1 (en) | Method and system for controlling data information between two portable medical apparatuses | |
MXPA01005388A (en) | A medical system and a method of controlling the system for use by a patient for medical self treatment |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
STCB | Information on status: application discontinuation |
Free format text: ABANDONED -- FAILURE TO RESPOND TO AN OFFICE ACTION |